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The invariant li chain (CD74) aids in the folding of MHC Class II in the 
endoplasmic reticulum (ER) by forming a complex structure with it.  Upon 
egress from the ER li acts as a chaperone for the MHC Class II molecules.  The 
N-terminal cytoplasmic region contains two di-leucine-based endosomal sorting 
signals that target the li chain from the Golgi apparatus and then to the 
endosomal/lysosomal compartments either directly from the Golgi apparatus or 
indirectly by trafficking via the plasma membrane 
Binding of the enzyme nitric oxide synthase 2 (NOS2) was previously shown to 
be at a site near the di-leucine based pair (LI) of the distal DXXXLI sorting 
motif.  In this project a 9-step gradient fractionation procedure to separate late 
endosome enriched from ER-enriched organelle fractions showed a greater 
accumulation of mouse li in the ER-enriched fraction of cells transfected with 
NOS2 compared to untreated control cells.  This was in agreement with 
immuno-fluorescent and confocal images of cells co-transfected with li and 
NOS2 which revealed that under high NOS2 expression li was confined to the 
perinuclear region and had fewer endosomal-like structures. 
We also investigated the effect of this motif on the internalization of mouse li 
and two mutant constructs.  Previous published results have shown that alanine 
substitutions for the second and third acidic amino acid residues of the 
membrane distal leucine-based sorting motif (DXXXLI) slowed down or 
abolished the internalization rate of li.  These studies were carried out in the 
context of mutations introduced to either delete the membrane proximal ML 
sorting motif or to render it non- functional.  In this project, the internalization 
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rates of two mutant li constructs in the membrane distal leucine-based motif 
were compared.  One mutant construct had an alanine substitution for the 
aspartate at position 6 (D6A) and the other consisted of a deletion of the first 
six N-terminal amino acids.  However, in both these mutant constructs the ML 
motif was kept intact.  It was found that with the membrane proximal ML motif 
kept intact the deletion mutant and D6A and truncated mutant constructs had an 
initial faster internalization rate compared to wild type li.  Confocal images also 
showed a greater co-localization with EEA1 positive structures for each of the 
two mutants in the initial phases of endocytosis compared to wild type li.  Co-
localization with EEA1 positive structures was seen even at 30 minutes 
however by this time point there was no marked difference between wild type li 
and the mutants.  Interestingly, no co-localization was observed with the late 
endosomal marker LAMP1 even after 2 hours.  This may indicate a transition of 
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1.1  Introduction to Antigen Processing 
Initiation of key aspects of the adaptive immunity is mediated through major 
histocompatibility complex Class I and Class II antigen presentation to T cells 
(Murphy et al., 2008).  Exogenous antigens that are internalized or that enter the 
cell are processed by proteolysis into small peptide fragments.  Individual 
fragments of these antigenic peptides are then loaded into the groove of the 
MHC I or II molecules which are brought to the surface and presented to T cells.  
Antigen presenting cells (APCs) such as dendritic cells (DCs), B cells, and 
macrophages are efficient at internalizing exogenous antigens.  They present 
the antigens through MHC Class II molecules to T helper cells, which have 
receptors to specifically recognize a particular peptide on the surface of MHC 
Class II (Cresswell, 1994).   
Key functions of the immune system are mediated through MHC Class II 
antigen presentation.  For example, B cells acquire the ability to differentiate 
into antibody producing plasma cells and macrophages are stimulated to 
become more aggressive at killing phagocytosed pathogens.  Most importantly, 
antigen presentation is the means by which DCs provide the necessary signal 
for activating and inducing the clonal proliferation of naive helper T cells 
(Steinman, 1991), with the consequence of initiating the adaptive immune 
system for the elimination of foreign microbes and antigens (Joffre et al., 2009).  
Of all APCs, it is only DCs which have been triggered into maturation by 
1 
 
microbial peptides that can prime naive helper T cells (Shortman and Naik, 
2007). 
1.1.1 The Role of Dendritic Cells in Regulating the Immune Response 
DCs constitute a heterogeneous group of very specialized cells that play a 
crucial role in controlling T cell immunity (Mellman and Steinman, 2001).  
DCs function in two maturation stages.  In the immature state DCs do not 
activate helper T cells because they express low levels of MHC Class II 
molecules and co-stimulatory molecules (Shortman and Naik, 2007) but have 
been described to act as sentinels that continually sample the tissue micro-
environment (Shortman and Liu, 2002) for microbial antigens and antigens 
derived from tissue damage.   
In presenting self-antigens from apoptotic tissues or innocuous antigens such as 
those derived from the microflora that colonizes the mucosal tissue (Soloff and 
Barratt-Boyes, 2010) DCs function to maintain tolerance (Shortman and Naik, 
2007).  However, upon ingestion of antigens derived from pathogenic 
components under inflammatory conditions DCs are activated to prime naive T 
cells (Ueno, et al., 2007).  DCs change their morphology and up-regulate the 
surface expression of MHC Class II molecules loaded with antigenic peptide 
(Villadangos et al., 2005).  Through this process of antigen presentation 






1.1.2  The Process of Antigen Acquisition  
MHC Class II molecules consist of two non-identical type I transmembrane 
polypeptide chains termed α and β subunits (Cresswell, 1994).  The luminal 
domains of the subunits fold into a groove in which antigenic peptides of the 
right size and conformation can fit (Landsverk et al., 2009).  In APCs the 
assembly of α and β subunits into dimers takes place in the endoplasmic 
reticulum (ER) in association with another protein, a type II membrane 
glycoprotein called the invariant chain CD74 or alternatively referred to as li 
(Stumptner-Cuvelette and Benaroch, 2002).  Three αβ-li complexes come 
together to form a nonameric complex (Cresswell, 1992) which exits the ER 
and is directed by the li chain to the endosomal/lysosomal compartments.  In 
these compartments, li undergoes proteolytic stepwise degradation from the C-
terminus to leave a small fragment called CLIP in the groove of the MHC Class 
II molecules.  CLIP is then removed to allow the loading of an antigenic 
peptide (Bryant et al., 2002). 
These series of events make clear that the acquisition of antigen which is the 
underlying key element for activating aspects of the immune system is very 
much dependent on the chaperone functions of li, which in turn is regulated 







1.2 Structure of the Invariant Chain li 
In humans four major isoforms of li exist. The major and minor isoforms (p33 
and p41) arise from an alternatively spliced exon such that the p41 contains an 
extra 64 amino acids.  Alternative mRNA translation sites give rise to the p35 
and p45 isoforms from the major and minor isoforms respectively.  These 
isoforms contain an extra 16 amino acids at the N terminus.  The extra amino 
acids encode a strong di-arginine (RXR) retention signal (Schutze et al., 1994; 
Khalil et al., 2003).  Trimeric complexes of li can accommodate any of the 
isoforms although the p33 and p35 isoforms are featured more prominently.  In 
the absence of MHC Class II, complexes that contain either the p35 or p45 
isoform are sequestered in the ER.  In mice only two isoforms are present and 
are referred to as p31 and p41.  Like the human counterpart they are formed 
from alternative mRNA splicing (Cresswell, 1994).   
The individual molecules of li assemble into a trimeric structure through 
interacting with each other at a protease resistant region located in the luminal 
domain.  Interaction of li with the αβ subunits of the MHC Class II molecules 
occurs through a small region upstream of the trimerization domain called CLIP.  
Binding of CLIP is believed to be necessary to prevent the binding of 
endogenous antigens in the ER (Stumptner-Cuvelette and Benaroch, 2002).  
The MHC Class II-li (αβ-li) complex associates with calnexin which stabilizes 
the formation of the complex.  Three αβ-li complexes associate together to form 
a nonameric structure.  Binding with MHC Class II enables the complex to exit 




1.3  The Intracellular Pathway of MHC Class II-li Complex 
Following its egress from the ER, the αβ-li complex traverses the Golgi 
network and from there it is transported to the endosomal/lysosomal 
compartments.  Two routes have been proposed in the transporting of li along 
the endocytic route (see figure 1.1).  One possibility is that li is transported 
directly from the trans-Golgi network (TGN) to the endosomal/lysosomal 
compartments.  The other hypothesis is an indirect route via the plasma 
membrane.  In this pathway, the αβ-li complex is delivered first to the cell 
surface, where it undergoes rapid endocytosis and eventually delivered to the 
late endosomal/lysosomal compartments (Stumptner-Cuvelette and Benaroch, 
2002; Landsverk et al., 2009).  Which of these is the major pathway has been 
debated and the conclusions reached depend in part on the main focus of the 
experimental approach.  The entry point to the ensosomal/lysosomal 
compartments in both pathways appears to be via endosomes.  In experiments 
where the early endosomes were ablated li did not reach the later endosomal 




























Figure 1.1 Assembly and Trafficking of MHC Class II-li complex.  MHC 
Class II are assembled in a nonameric complex in the ER (1).  They then leave the ER 
and traverse through TGN (2).  From the TGN, the αβ-li complexes are delivered to the 
endosomal/lysosomal compartments known as MIICs. This can happen via cell surface 
(3a) or by a direct route (3b).  In both pathways, the early endosomes serve as the entry 
point.  In MIICs li is digested (5) to a small fragment called CLIP (6).  CLIP is then 
removed and exchanged for an antigenic peptide (7). Antigenic peptides are derived 
from antigens that have been internalized and then cleaved.  The mature MHC-Class II 
complex is brought to the cell surface (8).  Material in the MIIC will eventually be 
brought into itra-luminol (ILV) compartments which fuse with lysosomes (Landsverk 
et al., 2009; Rocha and Neefjes, 2008; van Niel et al., 2008). 
 
 
1.3.1 The Nature of the Major Histocompatibility Type II Compartments 
The endosomal/lysosomal compartments have been termed MIICs (MHC Class 
II compartments) on the basis that these compartments are enriched in MHC 
Class II molecules (Harding, 1995).  However attempts to characterize MIICs 
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based on this definition yielded inconclusive results because peptide loading 
can occur in many places in the endocytic compartments (Rocha and Neefjes, 
2008).  Hence descriptions of the nature of the MIIC have ranged from early 
endosomal-like structures to a pre-lysosomal compartment that however is 
distinct from late endosomes because of the lack of the late endosomal markers 
(Neefjes, 1999).  
Despite these inconclusive findings, with regards to the αβ-li complex, it is 
appropriate to consider the MIIC as a dynamic compartment through which the 
αβ-li complex traverses.  The MIIC undergoes many stages of membrane 
maturation which begins with the formation of tubular structures from the outer 
delimiting endosomal membrane (van Neil et al., 2008).  These tubular 
structures undergo progressive morphological changes to eventually give rise to 
multi-vesicular and multi-lamellar structures.  The tubular extensions would 
represent the early stages of the endocytic compartment from where proteins 
are exported to the plasma membrane in budding vesicular structures.  The 
vesicular and lamellar structures represent the later stages of the maturation 
process (van Neil et al., 2008).  Proteins trapped in intra-luminal vesicles (ILV) 
are brought to degradative compartments when the ILV fuse with lysosomes.  
Such is the fate of old MHC Class II molecules that have been ubiquitinated 






1.4 Evidence for Trafficking of li via the Cell Surface 
The detection of li on the cell surface provided evidence that li does traffic via 
the cell surface membrane en route to the endosomal compartments.  However, 
it also sparked questions as to what proportion of the pool of newly synthesized 
li this indirect route represents.  
1.4.1 Detection of li on the Surface of Diverse Cells 
Support for an indirect route via internalization from the plasma membrane 
comes from the detection of surface expression of li on diverse cell lines.  
These cell lines include: JOK-1 (a B cell line derived from a patient with hairy 
cell leukemia); the T cell lymphoma HUT 78; Tonsiliar B cells; Raji Burkitt’s 
lymphoma; SK-MEL-37 and HT-29 tumour cell lines (Wraight et al., 1990; 
Koch et al., 1991; Ong et al., 1999).  All of these cells are MHC Class II 
expressing cell lines.   
The invariant chain li has also been detected on the surface of a B x T hybrid 
cell line (Henne et al., 1995) and on a B lymphoblastoid cell (Roche et al., 
1992).  These two cell lines have a defective mutation in the MHC Class II gene 
and so do not express MHC Class II but nevertheless still express li.  When 
compared to their respective MHC Class II expressing counterparts (the cells 
without the mutation defect) the surface expression levels and the 
internalization rate of li were very similar (Henne et al., 1995).  Furthermore, 
Roche and co-workers found that in the MHC Class II expressing variant, all of 
the surface invariant chain that was present on the surface of the cells was in a 
complex with the MHC Class II α & β dimers (Roche et al., 1992).  Taking 
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these data together shows that in cell lines that express normal levels of MHC 
Class II molecules li is present on the cell surface in association with the αβ 
chains of MHC Class II, but its surface expression however does not depend on 
concomitant expression of MHC Class II molecules. 
1.4.2 Experiments that Postulate a High Turnover Rate for li 
The surface expression of li is very low and it has led to the suggestion that the 
endoctyic route via internalization from the plasma membrane might only 
represent a minor pathway (Pieters et al., 1993).  However, the reason for the 
low surface expression may be due to the high turnover rate of li.  
Invariant chain that is expressed on the cell surface (sli) is rapidly internalized 
with a half-life of less than 5 minutes in some B and T lymphoma cell lines 
(Roche et al., 1992; Henne et al., 1995).  To put it in perspective, where in 
melanoma SK-MEL-37 cells the half-life for sli is less than 1 hour, the half-life 
for mature MHC Class II expressed on the surface of the same cell line is 
approximately 20 hours (Ong et al., 1999).  
Experiments involving prolonged continuous labelling of cells with saturation 
levels of anti-li and anti- DR antibodies allowed an estimate to be made of the 
number of αβ-li complexes present on the cell surface at steady state.  From 
these values and the internalization rate, the turnover of αβ-li complexes per 
day could be determined.  These calculations revealed a turnover rate of surface 
αβ-li complexes per day which could easily account for the number of mature 
MHC Class II molecules present on the cell surface at steady state.  This 
implies that the majority of αβ-li complexes traffic via the cell surface before 
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being internalized and transported to endosomal compartments.  The brief 
appearance of the αβ-li complexes on the cell surface would then account for 
the low numbers of surface li detected (Ong et al., 1999).  Furthermore, the 
time taken for newly synthesized αβ-li complexes to reach the cell surface must 
be short because treatment of cells with brefeldin A (which blocks exit of 
biosynthesized molecules from the ER) rapidly depleted the amount of αβ-li 
complexes at the cell surface.  Full restoration of surface expression of the αβ-li 
complexes occurred rapidly once the treated cells were grown in media without 
brefeldin A (Roche et al., 1992).  These findings are supported in a study by 
Saudrais and co-workers who found that αβ-li complexes appeared on the 
surface of immature human dendritic cells within 30 minutes after the 
complexes were synthesized (Saudrais et al, 1998) and is in line with studies 
which show that newly assembled αβ-li complexes are transported out of the 
ER within 30 minutes after the synthesis of li (Warmerdam et al., 1996). 
These studies suggest a model whereby newly synthesized αβ-li complexes are 
quickly routed to the cell surface.  Upon reaching the cell surface, the 
complexes are rapidly internalized and delivered to the endosomal/lysosomal 
compartments.  In the meantime new αβ-li complexes would arrive at the cell 
surface so that cumulatively the amount of αβ-li complexes which passage 
through the cell surface is high while at steady state, their cell surface 
expression remains low. 
Antibody mediated endocytosis however relies on the assumption that there will 
be one antibody molecule binding to one ligand in order to quantify receptor 
uptake.  Other methods of quantifying uptake have led to different conclusions.  
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Odorizzi and co-workers found that by using a transferrin receptor fused with 
the cytoplasmic tail of li, and measuring the amount of iron uptake, together 
with the rate of the synthesis and degradation of li, the surface pool of the 
chimera represented only about 19% of the total synthesized pool (Odorizzi and 
Trowbridge, 1997).  
Since the value for the surface pool of li derived from the transferrin receptor 
model assumed the accurate determination of four variables, Warmerdam and 
co-workers expressed reservations about accepting it as an absolute value for 
the proportion of li which traffics via the surface membrane.  Hence they took a 
different approach using a novel bio-assay which involved performing pulse- 
chase experiments for newly synthesized li that had been labelled with 
radioactive galactose.  After various chase periods the cells were treated with 
neuraminidase to remove sialic acid residues acquired by li, followed by a β-
galactosidase enzyme that specifically cleaved the terminal galactose residues 
which had become exposed once the sialic acid residues were removed.  In this 
way the radioactive galactose residues which had been incorporated in the 
newly biosynthesized li molecules which had reached the cell surface could be 
quantified.  While the assay did not allow the determination of the absolute 
proportion of the pool of newly synthesized li that trafficked via the cell surface, 
there was enough indication for Warmerdam and co-workers to conclude that 
the value they obtained was likely to represent a significant fraction 
(Warmerdam et al., 1996). 
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In summary the findings discussed above show that the perspectives gained on 
the significance of the trafficking of li via the cell surface depend on the 
inherent assumptions in the experimental conditions. 
 
1.5 Other Methods to Study the Trafficking of li 
At steady state li has been detected at different locations all along the endocytic 
route.  It was seen in budding vesicles from TGN that were identified as late 
endosomal structures (Kleijmeer et al., 1997).  On the other hand, other studies 
localized li to compartments with that were more characteristic of early 
endosomes (Romagnoli et al., 1993; Amigorena et al., 1994).  These differing 
conclusions reached do attest to the difficulty inherent in attempting to map a 
route for li at steady state from one organelle to another because only the end 
point is seen.  
In order to circumvent these difficulties, methods to disrupt the pathway of li 
(or the αβ-li complex) have been employed together with pulse-chase 
experiments.  When used in combination with immunocytochemistry and 
subcellular fractionation, it is possible to see where newly synthesized li 
accumulates.  In addition, surface biotinylation has been used to detect which of 
the newly biosynthesized li traffics to the plasma membrane.  In this way, such 
experimental approaches provide evidence of the intracellular trafficking route 





1.5.1 Evidence for Direct Trafficking to the Endosomal Compartments 
One particular study used mutant clathrin molecules called hubs in order to 
disable clathrin mediated transport (Liu et al., 1998).  The hubs could still 
interact and assemble into a complex with endogenous clathrin subunits but the 
clathrin structures formed were non-functional.  Immunofluorescence studies of 
HeLa cells transfected with these hubs revealed surface staining of li that was 
not detectable in cells treated with vector alone.  Surprisingly, the intracellular 
staining pattern was similar for both transfected and control cells, where li was 
localized in vesicular structures.  This led to the conclusion that sorting to 
endocytic compartments from the TGN is clathrin independent and is the 
preferred pathway otherwise li would have accumulated at the cell surface in 
hub transfected cells where endocytosis was impaired (Liu et al., 1998).    
One study used metabolically labelled Epstein Barr virus transformed B cells 
grown in the presence of concanamycin B (Benaroch et al., 1995).  This 
antibiotic inhibits vacuolar H+ATPases required for the acidification of 
intracellular organelles which appears to be important for the transport and 
delivery of cargo along the endocytic pathways.  
In cells cultured in the presence of concanamycin B, biosynthetically labelled 
MHC Class II molecules and as well as li became resistant to neuraminidase 
treatment at both 0 degrees (implying that most of the αβ-li complexes had not 
reached the cell surface) as well as at 37 degrees where neuraminidase was used 
as a fluid marker and allowed to internalize.  This suggested that the αβ-li 
complexes were present in an intracellular compartment not accessible to the 
internalized neuraminidase.  Electron microscopy revealed this compartment to 
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be MIIC.  Since only a minor fraction of αβ-li complexes were present at the 
cell surface after prolonged treatment with concanamycin B, the authors 
concluded that concanamycin B blocked the trafficking between the early and 
late endomsomes and that the majority of the αβ-li complexes had been 
delivered straight to the MIIC compartments downstream of the concanamycin 
B block (Benaroch et al., 1995). 
Combining metabolic labelling and dodecyl gel electrophoresis (DGE), Tulp 
and co-workers were able to compare the route of li with that of other 
molecules, namely: the transferrin receptor, MHC Class I (a molecule known to 
be delivered straight to the cell surface after biosynthesis) and MHC Class II 
(Tulp et al., 1994).  During the chase period, li, the transferrin receptor and 
MHC Class II molecules traversed via the early endosomes (EE ) while MHC 
Class I molecules went straight to the cell surface.  As the chase period 
continued, mature MHC Class II dimers eventually appeared on the plasma 
membrane while proteolytic fragments of li were located in the late endosomes 
(LE) indicating that li had become dissociated from the α and β chains of MHC 
Class II and was then delivered to the LE compartments.  These results suggest 
that li follows a route towards the LE from the ER via the EE before arriving at 
the late endosomal compartment without traversing through the cell surface 
(Tulp et al., 1994).    
1.5.2 Dual Pathway for li May Be Important for Antigen Presentation  
There were other experiments that reached the opposite conclusions and 
supported a route via the plasma membrane as the major route.  One approach 
involved the knock down of AP-1 and AP-2 complexes in stably transfected 
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HeLa cells that expressed MHC Class II and li (Dugast et al., 2005; 
McCormick et al., 2005).  This was done by using an RNA interference strategy 
consisting of short hairpin RNA which is converted to interfering RNA within 
cells against the γ and α subunits of AP-1 and AP-2 respectively.  In AP-2 
depleted cells, the αβ-li complexes accumulated on the cell surface whereas cell 
expression levels of the αβ-li complexes were normal in AP-1 depleted cells 
(Dugast et al., 2005; McCormick et al., 2005).  In another approach cells 
expressing an inducible dynamin mutant caused a selective accumulation of li 
on the cell surface upon induction (Wang et al., 1997). 
In conclusion it appears that both pathways are possible and the dominant 
pathway taken by li en route to the endosomal compartments may also depend 
on the particular cell type.  Saudrais and co-workers using surface biotinylation 
estimated that approximately 55% of the total proportion of newly 
biosynthesized αβ-li complexes travels via the cell surface.  Interestingly only 
7 % of the αβ-li complexes appeared on the cell surface in B cells (Saudrais et 
al., 1998).  It has been suggested that having a dual route to the 
endosomal/lysosomal compartments for the αβ-li complexes could allow entry 
at different points of these compartments and provide exposure to a wider 
variety of antigenic peptides for presentation (Landsverk et al., 2009).   
 
1.6  Transport of Protein Cargo in Membrane Bound Compartments 
The invariant chain li like other membrane bound proteins is transported to 
intra-cellular target destinations as protein cargo in transport vesicles which 
consist of spherical or tubular-like membrane-bound structures (Sandoval and 
15 
 
Bakke, 1994).  The soluble proteins on the other hand are transported in the 
lumen of these vesicles.  Transport vesicles carrying their cargo pinch off from 
a donor membrane and then fuse with another membrane of the target location.  
Intracellular transport is highly regulated thus enabling delivery of the protein 
cargo to the correct destination (Kirchhausen et al., 1997).  
1.6.1 Formation of Transport Vesicles 
The formation of vesicles is a multi-step process that in most cases begins with 
the assembly of proteins into a polyhedral lattice structure that coats a stretch of 
region on the cytosolic side of the donor membrane (Faini et al., 2013). 
As shown in figure 1.2, the protein coat causes a curvature to form along the 
membrane stretch on where it is assembled introducing an invagination called a 
bud that protrudes outwards into the cytoplasm (Doherty and McMahon, 2009).  
The two flanking ends on the noncytosolic side of that patch of the membrane 
are brought closer together until they eventually fuse effecting the formation of 
a protein coated vesicle that pinches off from the donor membrane (Sorkin, 
2004).  Once the vesicle is formed the protein coat is shed and the membrane 
vesicle is transported to its destination where it fuses with the target membrane 
(Robinson, 2004).  Examples of protein coats are COPI and COPII which are 
formed on transport vesicles at the ER and the Golgi cisternae (Barlowe, 1998; 
Kaiser and Ferro-Novick, 1998) and clathrin which coats vesicles that transport 





1.6.2 The Role of Associated Proteins in Cargo Transport 
Located between the donor membranes and the protein coats are a variety of 
other proteins each serving a particular function in the whole process related to 
the assembly of the protein coat, the initiation of budding, the formation of the 
protein coated vesicle and the release of the protein coat (Robinson, 2004).  
One such group of proteins associated with clathrin coated vesicles are the 
adaptor proteins.  As well as helping to form the protein coat, adaptor proteins 
have the important role of selecting and recruiting cargo proteins (Sorkin, 2004) 
into their specific transport vesicles (see figure 1.2).  
 
1.7 Adaptor Proteins 
Adaptor proteins recruit cargo into protein coats by binding to the cytoplasmic 
tails of membrane bound proteins and then sequestering them into the coated 
vesicles.  The adaptors recognize signals present on the cytoplasmic tails of 
type I and type II proteins (Kirchhausen et al., 1997) that direct their 
recruitment into transport vesicles as well as their trafficking itineraries along 
the biosynthetic and endocytic pathways (Sandoval and Bakke, 1994).  These 
signals are also important for mediating internalization from the plasma 
membrane (Kirchhausen et al., 1997). 
1.7.1 There Are Many Types of Adaptor Proteins 
Adaptor proteins consist of a family of proteins that share the common function 
of sorting cargo into transport vesicles.  Some of the adaptor proteins exist as 
protein complexes while others are monomers (Kirchhausen et al., 1997). 
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There are four main groups of adaptor protein complexes: AP-1, AP-2, AP-3 
and AP-4.  Each complex is a heterotetramer consisting of two large molecular 
weight subunits (approximately 90-130kDa), one medium polypeptide chain 
(~50 kDa) and one small chain (~20 kDa).  All of the subunits are called 
adaptins.  The two large subunits for AP-1, AP-2, AP-3 and AP-4 are 
designated as γ/β1, α/β2, δ/β3, and ε/β4 respectively (Boehm and Bonifacino, 
2001). 
The medium subunit for AP-1 to AP-4 is called µ1, µ2, µ3, and µ4 respectively. 
This subunit is connected to the β subunits in each case.  Similarly the small 
subunit is designated as σ1-4 for each of the respective adaptor proteins and is 
connected to the other large subunit.  From each of the large subunits extends a 
flexible random coil hinge region that has a special fold at the C-terminus 
which is referred to as the ‘ear’ (Robinson and Bonifacino, 2001). 
Different isoforms of the adaptins have been found giving rise to diversity 
within each of these four main types (Boehm and Bonifacino, 2001).  One of 
these isoforms is AP-1β which is expressed specially in polarized epithelial 
cells and is involved in basolateral sorting while AP-3β is neuron specific and is 
responsible for the formation of synaptic vesicles (Nakatsu and Ohno, 2003). 
Monomeric proteins have also been identified that share sequence homology to 
the adaptins.  One group is the GGA family of proteins.  These share a 28-38% 
amino acid sequence homology at the C-termimus domain with the ‘ear’ of γ 
adaptin (Boehm and Bonifacino, 2001).  The GGAs are clathrin associated and 
are involved with sorting proteins with the DXXLL motif (Bonifacino and 
















Figure 1.2 Formation of a protein coated transport vesicle.  The flanking ends 
of the non-cytosolic side of the membrane are brought closer together producing a 
protruding bud.  Associated proteins, such as the adaptor proteins help to assemble the 
coat and to incorporate protein cargo in the coat. Adaptor protein complexes (shown 
above) bind to the protein cargo as well as to the protein coat (1).  As the bud 
invaginates deeper into the cytosol, the protein coat complex becomes a bigger 
structure surrounding the protruding membrane (2).  The flanking membranes 
eventually fuse and the protein coated vesicles with incorporated cargo pinches off the 
donor membrane (3).  The protein coat is then shed (4) and the cargo is taken to its 





Another main group is the stonins.  The stonins in humans and mice are 
homologues at the amino acid level to the stone B proteins in Drosphilia, which 
share an amino acid homology with the μ subunits of the AP complexes 
(Boehm and Bonifacino, 2001).  However the stonins, unlike other adaptors, do 
not bind to the tyrosine or leucine-based sorting motifs and so are not directly 
involved in the sorting processes.  Rather, the stonins in humans have domains 
that can form an interacting network with other proteins that constitute the 
operative sorting processes in clathrin-dependent endocytosis (Robinson and 
Bonifacino, 2001).     
The structure of the adaptor complexes (see figure 1.3) makes them suitable for 
interacting with both the sorting signal of the cytoplasmic membrane bound 
proteins and with the subunits of the clathrin coat (Kirchhausen, 1999).  
There are also other proteins involved in cargo recruitment that do not share 
sequence homology with the adaptors and these are known as alternative 
adaptors.  Examples of these are the AP-independent adaptors such as the 
epsins and alternative adaptors such as the γ-synergins.  The γ-synergins bind to 
cargo but do not bind to the protein coat.  These other proteins however, are 
outside of the scope of this review (Robinson, 2004).  This review will focus on 
the adaptor complexes because they have been shown to bind to li.  
1.7.2 Roles of Adaptor Proteins  
AP-1 and AP-2 interact with clathrin through the β subunits and participate in 
the formation of clathrin coated vesicles (CCVs).  AP-1 has been localized at 




Figure 1.3   Adaptor proteins.  Adaptor proteins are associated with protein coats 
and help to recruit protein cargo into coated vesicles.  They share an amino acid 
homology across many species and with each other.  The ear domains at the N-
terminus of the GGAs share an amino acid homology with the ear domains of the 
adaptor complexes.  The MHD domain of the stonins shares an amino acid homology 
with the C-terminus of the μ subunit.  The adaptors can interact with each other 
through the ‘ear’ domains forming a complex network that is involved in the formation 
of coated vesicles and recruitment of cargo. Diagram adapted from (Robinson 2004). 
 
 
protein cargo in CCV and transport of cargo to the endosomes/lysosomes.  AP-
2 is involved in clathrin mediated endocytosis of cell surface proteins 
(Robinson and Bonifacino, 2001). 
 
Genetic defects in AP-3 in humans and mice (which parallel mutant models in 
Drosphilia) suggest that AP-3 is involved in the sorting processes at lysosomes 
and related organelles such as melanosomes (Nakatsu and Ohno, 2003).  It is 
not been clearly ascertained whether AP-3 is associated with clathrin or another 
protein coat.  AP-3 does possess a clathrin binding domain in its β subunit 
(Robinson and Bonifacino, 2001), and binding of AP-3 with clathrin has been 
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demonstrated in vitro (Nakatsu and Ohno, 2003) however purified clathrin 
coated membrane preparations are not enriched in AP-3 (Robinson and 
Bonifacino, 2001).  
Unlike the other three adaptors, AP-4 does not appear to be associated with 
clathrin and accordingly lacks a clathrin binding box which suggests a role for 
AP-4 in clathrin-independent transport.  AP-4 has an apparent function in 
basolateral sorting (Nakatsu and Ohno, 2003). 
 
1.8  Sorting Signals on the Cytoplasmic Tail of Membrane Bound 
Proteins 
In order to be able to recruit protein cargo into transport vesicles, the adaptors 
recognize signals present in the cytoplasmic tails of type I and type II proteins 
(Kirchhausen et al., 1997).  These signals direct the trafficking itineraries of 
membrane bound proteins along the biosynthetic and endocytic pathways and 
are also important for mediating internalization from the plasma membrane 
(Robinson, 2004). 
1.8.1 Sorting Signals Consist of Conserved Motifs 
Signals on the cytoplasmic tails of Type I and type II membrane proteins 
consist of a variety of sorting motifs.  Although diverse, common patterns can 
be recognized (Kirchhausen et al., 1997).  One group contains a critical tyrosine 
residue for the signal to be functional.  The other group of motifs have been 
collectively referred to as di-leucine based motifs (or simply leucine-based 
motifs) and feature a double leucine base pair or variations of it where one of 
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the leucine “Leu” amino acids can be replaced by isoleucine “Ile”, valine “Val” 
or methionine “Met,” (Sandoval and Bakke, 1994). 
1.8.2 Tyrosine Based Motifs 
There are two distinct classes of tyrosine based motifs.  One of these consists of 
the FXNPXY sorting signal (where X is any amino acid), which is found in the 
LDL receptor family of proteins, as well as the insulin and EGR receptors. 
However this sorting signal is only involved in endocytosis and not in other 
intracellular sorting processes (Bonifacino and Traub, 2003).  
The other tyrosine based class of signals are characterized by the YXXØ motif 
where X is any amino acid and Ø is a bulky hydrophobic amino acid (Nakatsu 
and Ohno, 2003).  This motif is distributed amongst a wide variety of 
membrane proteins and can act as an internalization signal, as in the case of the 
transferrin receptor, and as an intracellular sorting signal, as in the lysosomal 
protein LAMP 1 (Heilker et al., 1999). 
1.8.3 Di-leucine Based Signals 
The di-leucine based motifs consist of the consensus amino acid sequence 
D(E)XXXLL(I) where X is any amino acid residue and as mentioned above, 
one of the leucines, usually the second one, can be replaced by isoleucine.  
Amino acid residues -4 (or at times -5) from the first leucine are acidic and are 
critical for the function of this motif (Bonifacino and Traub, 2003).  
As for the YXXØ motif, the D(E)XXXL(I) motif is also found in many 
different types of proteins of diverse functions and consequently is involved in 
internalization and in intracellular signalling events, including basolateral 
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sorting in polarized epithelial cells.  Examples of proteins containing the di-
leucine based motif are the T receptor complex component CD3γ, the 
lysosomal associated protein LIMP II, where in both cases the di-leucine based 
motif mediates internalization, and tyrosinase, where the motif is necessary for 
targeting to the lysosomes (Kirchhausen et al., 1997). 
A related type of di-leucine based motif is the DXXLL motif.  This motif is 
normally found in a cluster of acidic amino acids.  The aspartic amino acid is 
crucial to its function.  This motif binds to the VHS domains of the GGAs and 
is involved in sorting from the TGN to endosomes (Bonifacino and Traub, 
2003). 
1.8.4 The Sorting Motif of li 
The invariant chain (li) is a type II protein that contains two di-leucine based 
sorting motifs in its cytoplasmic tail that function to target the αβ-li complex 
along the endocytic route and also mediate its internalization via the plasma 
membrane (Landsverk et al., 2009). 
Site directed mutagenesis identified the di-leucine based pairs in human li as 
Leu7/Ile8 and Met16/Leu17 (Bremnes et al., 1994).  The di-leucine based motif 




Figure 1.4 The sorting motif in the li chain of different species.  The D (E) 
XXX L (L) motif in four different species is shown here in red.  The full sequence of 
the human and mouse cytoplasmic tail is shown.  For the other two species, the number 
of amino acid residues from the C-terminal end to the membrane is indicated.  TM, 
transmembrane.  (Sequences are from the review by Bonifacino and Traub, 2003). 
 
 
1.8.5  The Acidic Amino Acids are Crucial to the Function of the Motif  
In addition to the di-leucine motifs, amino acid residues located in the 
proximity of these motifs have also been shown to be important for (1) efficient 
internalisation and (2) the formation of large endocytic vesicles. 
In order to study whether both di-leucine motifs are required for internalisation 
and endocytic targeting, mutant constructs were generated where one of the 
pairs of signals was either mutated or deleted.  These studies showed that at 
least one of the pair of di-leucine motifs is required for internalization to take 
place.  In these mutant constructs with only one functional di-leucine pair, 
substituting an alanine for any of the amino acids of that one di-leucine pair 
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results in the abolishment of internalization (Bremnes et al., 1944).  Hence for 
internalization to take place at least one of the Leu/Ile or Met/Leu pair must be 
present and both of the amino acids of the di-leucine pair that is present must be 
intact.  
Based on the compiled data of a couple of studies, besides the Leu/Ile motif 
aspartic acid at position 3 (Asp3) is crucial for internalization.  Mutants with an 
alanine substitution for aspartic acid at position 3 (D3A) were unable to be 
internalized by the cell (Motta et al., 1995; Pond et al., 1995) while the effect of 
substituting aspartic acid with alanine at position 2 (D2A) abolished 
internalization in one study (Pond et al., 1995) and slowed down internalization 
in another study (Motta et al., 1995).  An alanine substitution for glutamine 
(Gln) at position 4 (Q4A) slowed down the internalization rate (Pond et al., 
1995), or abolished internalization entirely (Motta et al., 1995).  Alanine 
substitutions at positions 5 & 6 did not affect internalization (see figure 1.5).   
Interestingly, substituting aspartic acid with glutamic acid at position 2 and 3 
respectively (D2E and D3E) in mutants containing only the Leu/Ile motif did 
not affect internalization.  This was also case when glutamic acid was 
substituted with aspartate (E12D) in mutant constructs containing only the 
Met/Leu motif (Pond et al., 1995).  However, if these amino acid substitutions 
were made with the uncharged polar amino acid asparagine (that is, D2N and 
D3N in Leu/Ile only constructs) then internalization was abolished (Pond et al., 
1995).  This implies that the acidic amino acids are crucial for internalization at 




In the studies above, the presence of large endocytic vesicles were observed in 
the constructs where li was internalized.  To investigate whether the formation 
of intracellular vesicles always occurred upon internalization Pond and co-
workers generated constructs of lip31 where the N-terminal di-leucine signal 
was replaced with the di-leucine based sequences of other proteins, namely: 
human limpII, mouse CD3γ, bovine CI-M6P; and human CD4.  Hence, the di-
leucine based motif was still present in the cytoplasmic tail of li but the amino 
acid sequence of the motif was changed. 
Except for human CD4, all contained two acidic amino acids at the N-terminal 
end.  Mutating these amino acids to alanine surprisingly did not alter the 
internalization but affected the formation of large endocytic vesicles.  This 
suggests that it is not the specific properties of the acidic amino acids alone that 
determine the function of the di-leucine based motif, but rather that the 
particular amino acids are operative and are recognized within the structural 
content of the whole DDQXXLI motif (Pond et al., 1995).  These results also 
imply that the di-leucine based signal functions slightly different in the sorting 
process to intracellular membrane compartments compared to the way it does in 
endocytosis (Kang et al., 1998).  
The cytoplasmic tail of li also contains signals that target the molecule to the 
basolateral membrane in polarized cells.  Studies with deletion mutants have 
mapped this region as the segment from amino acid residue 20 to amino acid 
residue 30.  This seems to be required in addition to the di-leucine motifs for 





Figure 1.5 Schematic representation on compiled data of amino acid 
substitutions/ deletions in the di-leucine based motifs of the human li chain.  The 
mutations in these studies were carried out with respect to one functional di-leucine 
based pair.  The other pair was either deleted or mutated. Mutations are shown in red; 
the motif is shown in black; other amino acids are in grey. Compiled from Motta et al., 
1995 and Pond et al., 1995. 
 
1.8.6 Structure-function Relation of the Di-leucine Based Motif   
The specific requirement for an acidic amino acid at position 2 and 3 
(especially 3) for efficient internalization possibly indicates that the Leu/Ile 
motif is recognized as part of a larger secondary structure within the context of 
other amino acids that are in the proximity of the motif.  
NMR spectroscopy of a synthetic peptide consisting of the first 27 amino acids 
of the human li cytoplasmic tail revealed that the structure of the cytoplasmic 
portion of li consists of an α-helix from amino acid residue glutamine 4 to 
leucine 17.  At Leu14 there is a minor variation in the structure consisting of a 
type 1 β-turn (Leu14-Leu17).  This type 1 β-turn seems to be accommodated 
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within the overall α-helix structure such that only Leu14 shows a minor 
conformational change within this segment; the rest of the short segment 
conforms to the α-helix structure.  The amino acid proline 15 introduces a kink 
within the helix.  There are also two type II β-turns encompassing Arg20-Ala23 
and Ala23-Ser26 in the membrane proximal region (Motta et al., 1995). 
The secondary structure reveals that Glu4 and the Leu/Ile motif lie on the same 
side of the α-helix so that they are in spatial proximity, whereas the amino acids 
Arg5 and Asp6 are located on the opposite side of the α-helix.  Hence it appears 
that mutating only those amino acids within the spatial proximity to the Leu/Ile 
motif affects internalization; spatially distal amino acids can be mutated without 
affecting the function.  This would indicate that the motif is recognized together 
with amino acids in close spatial arrangements.  The amino acid Asp 3 however, 
does not lie within spatial proximity, but the acidic side chain seems to be 
required for maintaining the stability of the α-helix by forming a hydrogen bond 
with the free amino (NH) groups at the N-terminus (Motta et al., 1995).  
1.8.7 The Role of the Motif in Forming Large Endocytic Vesicles  
Further investigation by Nordeng and co-workers on the relation between the 
sorting motif and internalization event showed that the information for 
vacuolation does indeed lie within the first six amino acids residues but 
surprisingly the process was not dependent on any one of these amino acid 
residues in particular but on the presence of at least one free negative side chain 
that does not form a salt bridge interaction with any of the other amino acids 
that lie three residues away (Nordeng et al., 2002).  The authors suggested that 
the free side chain might be involved with other membrane proteins to bring 
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about fusion of endosomes and that the charge distribution of the motif 
favoured the folding of the li cytoplasmic tail into a trimeric α-helix bundle 
which was important for the various li cytoplasmic tails to be able to interact 
with one another (Nordeng et al., 2002).  Notably, the formation of large 
vesicles did not occur with dimeric and tetrameric quaternary structures of the 
lumen domain of li as is found in chimeric constructs consisting of the 
cytoplasmic tail of li fused with neuraminidase (Bremnes et al., 1994) which 
form a tetrameric structure. 
It was suggested that the formation of large endosomal-like vesicles may affect 
a delay in the fusion of the endosomal vesicles with lysosomes which may 
serve to retain cargo in endosomal structures for longer (Gregers et al., 2003).  
Accordingly, wild type li displayed a longer half-life compared to its mutant 
counterpart where aspartic acid at position 6 was substituted for arginine (D6R). 
As well as having a shorter half-life, the D6R mutant did not show vacuolation 
in transfected cells.  This correlated with more potent antigen presentation 
ability in cells transfected with wild type li.  All these findings together indicate 
that the endosomal retention activity that results from vacuolation may delay 
degradation of li in order to optimize conditions for antigen loading (Gregers et 
al., 2003). 
 
1.9  Binding of Adaptor Proteins to the Sorting Motifs of li 
Techniques such as immunoprecipitation and Surface Plasmon Resonance (SPR) 
analysis have shown binding of adaptor proteins to the motifs of many proteins.  
In some cases such as with the binding of AP-2 to tyrosine based motifs, 
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structural data is available.  However no structural data seems to be available 
yet for binding of adaptor proteins to the D(E)XXXL(I) motif (Heilker et al., 
1999). 
There were studies that suggested that AP-1 is not required for sorting of li 
(Glickman et al., 1996; Liu et al., 1998).  However, the first evidence for 
intracellular interaction between AP-1 and li came from Salamero and co-
workers.  Addition of a soluble tissue extract rich in AP-1 to HeLa cells 
transfected with the MHC Class II dimers and li showed a marked recruitment 
of AP-1 to the perinuclear region which co-localized with li.  Recruitment was 
ARF dependent because it could be inhibited by brefeldin A and did not occur 
in cells transfected with a truncated li construct lacking the DXXXLI motif 
(Salamero et al., 1996).   
Rodionov and Bakke then showed that the isolated subunits μ1 and μ2 subunits 
of AP-1 and AP-2 respectively could interact with the cytoplasmic tail of li and 
this interaction was dependent on the membrane distal Leu-Ile signal (Rodionov 
and Bakke, 1998).  A random phage display library revealed that binding to the 
leucine based motifs occurred through a conserved sequence in the μ1 and μ2 
subunits (Bremnes et al., 1998).  Interestingly, using a photoactivated cross-
linking method, binding of AP-1 to the leucine based motifs of other proteins 
was shown to occur via the β subunit of AP-1 (Rapoport et al., 1998). 
Quantification of the binding affinities of AP-1 and AP-2 to immobilized 
peptides of trimeric and monomeric forms of the li cytoplasmic tails using SPR 
analysis revealed that AP-1 bound with a fourfold greater affinity compared to 
AP-2.  In each case binding was dependent on the di-leucine based motifs with 
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a greater affinity to the Leu-Ile (LI) pair compared to the Met-Leu (ML) pair.  
Substitution of any one of the LI or ML amino acids for alanine greatly 
diminished the binding affinity (Hofmann et al., 1999).   
Interestingly, mutations of the acidic amino acids at the di-leucine distal motif 
(Asp2 and Asp3 in the context of a Leu17 to alanine substitution) resulted in 
significantly reduced binding of AP-2 in a SPR assay.  This correlates with the 
finding that Asp2 and Asp3 are required for internalization and provides 
support that internalization of li is a clathrin-mediated process mediated by AP-
2 (Kongsvik et al., 2002).  Finally, AP-1 and AP-2 displayed different 
specificities for binding to the various mutants.  The authors concluded that this 
was at the level of the primary structure. 
 
1.10 Sampling of Antigens by DCs 
The invariant chain li plays the key role as a chaperone for MHC Class II for 
antigen presentation in APCs.  This becomes important in DCs since they are 
the only APCs that can activate and regulate the whole immune system. 
In the immature state DCs are very efficient at capturing and processing 
antigens for presentation to T cells on MHC Class I and MHC Class II 
molecules (Mellman and Steinman, 2001).  They do this through 
macropinocytosis and receptor mediated endocytosis (Thery and Amigorena, 
2001) hence they are capable of presenting a diverse array of antigens including 
self-antigens shed from the turnover of host cells, microbial antigens from the 
microflora of mucosal tissues and components from a wide variety of pathogens 
including fungi, bacteria, viruses and parasites (Reis e Sousa, 2006).  
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Phenotypic and functional studies have led to the categorization of human and 
mouse DCs into two broad groups-the conventional DCs (cDCs) and precursor 
DCs (pDCs).  There are some morphological and functional differences 
between the two groups (Liu, 2001).  The pDCs are at the last developmental 
stage towards becoming mature DCs, which happens upon microbial 
stimulation under inflammatory conditions.  
Conventional DCs consist of those DCs that reside in lymphoid tissues and 
those that are found in peripheral tissues such as the dermis of the skin, and 
under the surface epithelia of respiratory, reproductive and gastrointestinal 
mucosal tissue (Soloff and Barrat-Boyes, 2010).  The DCs that reside in the 
mucosal tissues are able to ingest antigens common to surface epithelial tissues  
(Mellman and Steinman, 2001) by using their extensive dendrites to form a 
network with the surface epithelial cells (Soloff and Barrat-Boyes, 2010).  One 
group of these peripheral DCs, upon ingesting the antigens, migrate to the 
nearest lymph node where they present the processed antigenic peptides to the 
T cells (Steinman and Naik, 2007).  The widespread distribution of DCs 
amongst different organs and surface epithelia (Steinman, 1991) and the 
migratory abilities of DCs enable them to bring a vast array of antigens to T 
cells (Reis e Sousa, 2006).  
1.10.1 DCs and Macrophages are activated through the Recognition of 
PAMPS 
DCs are able to recognize and distinguish microbial antigens from self-antigens 
through a set of receptors located both at the cell surface and in 
endosomal/lysosomal organelles (Iwasaki and Medzhitov, 2010).  These 
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receptors recognize conserved microbial molecular constituents which consist 
of regular structural molecular patterns (Janeway and Medzhitov, 2002).  These 
common components of microbes are denoted by the general term pathogen 
associated molecular patterns (PAMPS) and include lipopolysaccharide (LPS) 
of the cell wall of gram positive bacteria, mannose rich oligosaccharides, 
peptidoglycan and single stranded or double stranded viral DNA/RNA (Kumar 
and Akira, 2011).  The group of receptors that recognize PAMPS are called 
pattern recognition receptors (PRRs) and several types have been characterized 
(Ueno et al., 2007).  These include toll-like receptors (TLRs), cell surface C-
type lectin receptors (CLRs), intracytoplasmic nucleotide oligomerization 
domain (NOD)-like receptors (NLRs) and retinoic acid inducible gene (RIG-I) 
receptors (Ueno et al., 2007; Iwasaki and Medzhitov, 2010).  Besides DCs, 
PRRs are also components of macrophages and other leukocytes such as 
neutrophils, eosinophils, mast cells and NK cells (Janeway and Medzhitov, 
2002).   
Macrophages and DCs are activated through the recognition of PAMPS which 
trigger an array of intracellular signalling pathways (Kumar et al., 2011).  In the 
case of DCs, it leads to their maturation which is characterized by an increased 
expression of MHC Class II–peptides, an upregulation of surface co-stimulatory 
molecules CD80 and CD86 and adhesion molecules (Mellman and Steinman, 
2001).  This equips the DC for antigen presentation to T cells.  However, in 
steady state when there is no infection present, DCs are described as being 
tolerogenic (Steinman et al., 2003; Reis e Sousa, 2006; Joffre et al., 2009).  It is 
only upon recognition of PAMPS in the presence of an infection and 
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inflammation that DCs are stimulated to become immunogenic and prime naive 
T cells (Reis e Sousa, 2006; Joffre et al., 2009).  A distinct group of short lived 
migratory DCs called inflammatory DCs are also activated in response to 
inflammatory stimuli that result from microbial invasion (Shortman and Naik, 
2007) 
1.10.2 Recognition of PAMPS Stimulates Macrophages and DCs to 
Produce Nitric Oxide 
Recognition of PAMPS such as LPS by macrophages in the presence of IFN-γ 
(secreted by Th1cells) stimulates the macrophages to make nitic oxide “NO” 
(Green et al., 1991; Wanasen and Soong, 2008), which is an important 
molecule which has diverse roles in the immune system (Bogdan, 2001). 
IFN-γ can interact synergistically with TNF-α to enhance the production of NO 
in macrophages (Nathan, 1991).  This is immunologically significant because 
TNF-α is one of the pro-inflammatory cytokines secreted by LPS stimulated 
macrophages (Macmicking et al., 1997).  
As well as macrophages, other cells of the immune system also produce NO 
such as neutrophils, NK cells, mast cells, eosinophils and DCs (Bogdan, 2001).  
Non-immune cells such as fibroblasts, keratinocytes and hepatocytes can also 







1.11 The Role of Nitric Oxide in Biological Systems 
NO is a radical gas with a very short half-life.  It is water and lipid soluble 
hence it can diffuse through cell membranes and react easily with several 
intracellular proteins (MacMicking et al., 1997).   
Besides playing a role in the immune system NO displays a variety of effects in 
physiological processes (Stankevicius et al., 2003).  NO secreted by endothelial 
cells has been shown play a role in inducing vasodilation (Moncada and Palmer, 
1988) through its effects on causing relaxation of vascular smooth muscles 
(Stankevicius et al., 2003).  In addition, NO inhibits platelet aggregation and 
blood clotting (Bredt, 1999; Stankevicius et al., 2003).  NO has been found to 
be secreted by vasodilator neuronal cells in the brain where it helps to regulate 
the blood flow (Bredt, 1999).  The myosentric complex in the intestine also 
secretes NO which then acts on adjacent smooth muscles causing the regulation 
of muscular activity (Bredt, 1999).  In the immune system, NO has plays an 
immunomodulatory role through the control of cytokine secretion and the 
activity of immune cells (Bogdan, 2001) and displays microbicidal activity 
(Fang, 1997). 
NO anti-microbial activity occurs either through the direct action of NO itself 
on the microbes or via the reactive products it forms inside the cell 
(Chakravortty and Hensel, 2003).  The NO radical can react with oxygen to 
form products of various oxidation states of NO for example, NO2, NO2- , NO3-
(Nathan and Shiloh, 2000).  Chemical reaction of NO with these intermediates 
give rise to other unstable adducts of NO such as N2O3, N2O4 (Fang, 1997; 
MacMicking et al., 1997).  Reaction of NO with reduced thiols forms S-
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nitrosothiols, which can then yield NO+ (MacMicking et al., 1997).  In 
phagocytic cells NO can react with superoxide (Fang, 1997) to form the 
destructive peroxynitrite (OONO-).  These nitrogenous products formed from 
NO are collectively called reactive nitrogen intermediates (RNI).  The 
denotation of NO (without the dot) has been used to refer collectively to the NO 
radical itself and to its reactive products (Bogdan, 2001).  We will follow this 
convention in this review.  (In some publications a dot is written next to the 
‘NO’ to underscore that it is the radical itself, that is, NO∙).  
NO can damage DNA (Nathan and Shiloh, 2000) through deamination causing 
strand breaks (Fang, 1997).  NO modification of protein structure can occur 
through nitration of tyrosine residues, S-nitrosylation of thiol groups, 
interaction with heme groups (Fang, 1997) and disruption of Fe-S clusters 
(Fang, 1997; Bogdan, 2001). 
1.11.1 Nitric Oxide is produced from L-arginine by Nitric Oxide Synthases 
NO is produced as an immediate reactant product in the synthesis of the stable 
end products which are nitrite (NO2-) and nitrate (NO3-) from the substrate L-
arginine.  The reaction is catalysed by a family of three enzymes known as NO 
synthases (Chakravortty and Hensel, 2003).   
The nomenclature for the NO synthases reflects the tissues from which they 
were isolated.  Hence the NO synthase cloned and purified from neuronal cells 
and endothelial cells are known as nNOS and eNOS respectively.  The third 
NOS, which was cloned from macrophages, is called iNOS, where the letter ‘i’ 
denotes both ‘inducible’ and ‘independent’ (Chakravortty and Hensel, 2003).  
37 
 
One reason for this designation is to signify that iNOS is independent on 
increased levels of intracellular Ca2+ for its biological activity, in contrast to 
nNOs and eNOS, which require elevated levels of intracellular Ca2+. 
(MacMicking et al., 1997).  That iNOS is inducible also contrasts with nNOS 
and eNOS which are constitutively expressed in their respective cells 
(MacMicking et al., 1997).  Another classification of the NO synthases is based 
on the order in which their respective DNA clones were isolated.  In this system, 
the NO synthases are termed NOS1, NOS2 and NOS3 which correspond to 
nNOS, iNOS and eNOS respectively (Michel and Feron, 1997).  We shall 
employ this terminology in this literature review. 
Since their isolation and characterization, NO synthases have been found in a 
wide variety of cells besides those from which they were at first isolated.  
NOS1 also occurs in skeletal muscle (Michel and Feron, 1997).  NOS2 is the 
most widely distributed of the three (MacMicking et al., 1997) and is also 
expressed in such cells as neutrophils, fiboblasts (Liew et al., 1997), glial cells, 
vascular smooth muscle cells (Michel and Feron, 1997) and keritonocytes 
(Kronche et al., 1998).  NOS3 has been found to be expressed in cardiac 
myocytes and blood platelets (Michel and Feron, 1997). 
The three NO synthases share an overall amino acid homology of 
approximately 55% (Michel & Feron, 1997), showing a high level of sequence 
conservation in structural domains that are important for catalysis (Liew et al., 
1997) and divergence at the segments in between the domains (Daff, 2010).  
The conserved regions contain binding sites for co-factors that are involved in 
the catalysis reaction.  The N-terminal region binds iron protoporphyrin and the 
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redox co-factor (6R)-5, 6, 7, 8-tetrahydrobiopterin (H4B) and forms the 
oxygenase domain.  The C-terminus has binding sites for FMN, FAD, NADPH 
and functions as the reductase domain (Groves & Wang, 2000; Li & Poulos, 
2004).  The two domains are connected by a segment containing a calmodulin 
(CaM) binding site (Daff, 2010).  CaM binding is required for triggering 
electron transfer to the heme (Stuehr, 1999).  
In its active form NO synthase is a homodimer with H4B being located at the 
dimer interface (Daff, 2010).  NOS1 and NOS3 require Ca2+ for the binding of 
CaM whereas for NOS2 CaM binds irreversibly and occurs during the assembly 
of the enzyme (Stuehr, 1999).  Thus NOS2 is continually active once assembled 
and as long as a stimulus is present can produce abundant quantities of NO for 
long periods (hours to days).  This contrasts with NOS1 and NOS3 that can 
produce NO for a few minutes in response to stimuli (Chakravortty and Hensel, 
2003).   
The three NO synthases catalyse the synthesis of NO from L-arginine.  The first 
step involves the hydroxylation of L-arginine to give N-hydroxy-L-arginine as 
an intermediate, which is further oxidized to generate citrulline and NO 
(Marletta et al., 1998).  During the catalysis reaction electrons donated by 
NADPH are transferred via FAD and then FMN in the reductase domain to the 






1.12 The Role of Reactive Nitrogen Intermediates (RNI) as Anti-
microbial Agents 
The NO produced by macrophages that have been activated with LPS and IFN-
γ is a major factor contributing to the microbicidal properties of these 
macrophages.  This has been shown in cell culture where there was a 
correlation between increased levels of NO production (measured by nitrate or 
nitrite output in the media) and the killing of intracellular organisms such as 
Leismania major and Leishmania enrietti (Mauel, et al., 1991), Toxoplasma 
gondii (Adams et al., 1990), Mycobacterium bovis (Flesch and Kaufmann, 
1991), Mycobacterium tuberculosis (Chan et al., 1992) and extracellular 
pathogens such as Trypanosoma musculi (Vincendeau and Daulouede, 1991) 
and  Schistosoma mansoni (James and Glaven, 1989).  Inhibition of NO 
production either through the use of L-arginine analogs, in particular NG-
monomethyl arginine (L-NMMA), or through depletion of L-arginine in the 
media or digestion with L-arginase, reversed the growth inhibition exerted on 
the microbes in each of these cases and resulted in an enhancement of their 
growth.  
Evidence for NO microbicidal activity in vivo was provided when mice infected 
with L. major were treated with L-NMMA which resulted in a significant 
increase in the number of live parasites in the footpad lesions compared to 
control mice (Liew et al., 1990).  In another in vivo study, there was a direct 
relation between urinary NO3-output and an increase in survival time of BCG-
vaccinated mice that were challenged with a lethal dose of the gram negative 
Francisella tularensis.  Treatment of the vaccinated mice with L-NMMA 
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resulted in an exacerbation of the disease and a proliferation of the bacteria in 
the peritoneum of the mice (Green et al., 1994). 
1.12.1 The role of NOS2 in the Immune System 
The direct involvement of NOS2 in NO production was shown in murine 
peritoneal macrophages which were infected with L. major amastigotes and 
then treated with IFN-γ and L. major amastigotes.  Increased nitrate production 
correlated with an increase in NOS2 expression as assessed by immunoblot.   
Conversely there was reduced NOS2 expression when NO production was 
inhibited through the application of NMMA and anti-TNF antibody (Green et 
al., 1994).    
Other related studies provided evidence that an increase in NOS2 expression 
was associated with resistance to certain pathogens.  Barrera and co-workers 
found that when splenic macrophages from BCG-resistant mice and BCG- 
susceptible mice were stimulated with IFN-γ, the macrophages from the BCG- 
resistant mice showed a higher level of nitrite output and a corresponding 
increase in NOS2 mRNA expression (Barrera et al., 1994).  In another study, it 
was found that T. gondii could proliferate in rat alveolar macrophages but 
actually diminished in numbers in the peritoneal macrophages of the same rats.  
The peritoneal macrophages showed a higher ratio of NO production/arginase 
activity which could be accounted for by a significantly higher NOS2 
expression in these cells (Zhao et al., 2013).  This finding was supported by in 
vivo studies where rats were infected with T.gondii tachyzoites using either the 
peritoneal route or the pulmonary route.  Immunohistochemical staining 
revealed the presence of tachyzoites in the lungs of the rats infected via the 
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pulmonary cavity which showed that the parasite could multiply in the alveolar 
macrophages rendering the lungs more susceptible.  By contrast, in the rats 
injected via the intraperitoneal route, no parasites were found in any of the 
major organs, including the lungs, implicating that the killing of the parasites by 
the rat peritoneal macrophages was due to increased NOS2 expression and 
consequent NO production (Zhao et al., 2013). 
Other vaccination studies, this time to induce resistance in mice against 
Schistosoma mansomi were carried out by vaccination of mice with radiation 
attenuated cercariae.  Analysis of mRNA expression levels in the lung tissue 
extracts from vaccinated and control mice after challenge with transformed 
cercariae showed that NOS2 mRNA levels increased in both vaccinated and 
control mice, but in vaccinated mice the peak increase occurred one day earlier 
with levels that were ten-fold higher compared to control mice.  NOS2 mRNA 
expression could be supressed with anti-IFN-γ antibodies, which resulted in an 
increase in worm burden (Wynn et al., 1994). 
Studies using NOS2 genetically deficient mice (NOS2-/- mice) enabled the 
effects seen to be attributable directly to NOS2, thereby establishing a definitive 
role for NOS2 in vivo.  The NOS2-/- knockout mice have been shown to be 
more susceptible to death following infection with Mycobacteria tuberculosis 
compared to wild type mice (MacMicking et al., 1997).  In the same study, 
NOS2-/- mice resembled wild type mice treated with glucocorticoids, and 
treatment of the mutant mice with glucocorticoids did not render them any more 
susceptible implying NOS2 played a central role in resistance to TB 
(MacMicking et al., 1997).  NOS2-deficient mice are more prone to infection 
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with ectromelia virus which causes mousepox (Nathan, 1997).  Severe 
septicaemia and death followed within 6 days upon injection of S. enterica in 
NOS2-deficient mice whereas the wild type mice survived (Chakravortty and 
Hensel, 2003). 
NOS2-deficient mice were unable to control the replication of Leishmania 
major promastigotes (Liew et al., 1997) which contrasted to wild type mice and 
mice heterozygous for the NOS2 gene which showed healing from the pathogen. 
In other instances of host defence, NOS2 may not be crucial for survival of the 
host, but nevertheless still contributes to controlling the spread of infection.  An 
example of this is seen in NOS2-/- mice infected with Toxoplasma gondii which 
are still able to control the systemic spread of the tachyzoite in the early stages 
of infection despite the lack of NOS2.  A corollary to this was seen with the 
administration of L-NMMA to wild type mice in the early stages of the 
infection, where the disease did not get worse.  However, administration of L-
NMMA to chronically infected wild type mice caused a reactivation of the 
infection as seen by an increase in parasite brain cyst burden and worsening of 
the disease severity (Scharton-Kersten et al., 1997). 
Initial experiments to confirm NOS2 expression in human macrophages yielded 
mixed results.  However, Denis and co-workers showed that macrophages 
cultured from venous blood of healthy donors could inhibit the intracellular 
growth of avirulent strains of Mycobacterium avium in culture and that 
treatment with TNF-α enhanced the ability of the macrophages to inhibit the 
growth of the bacilli by as much as tenfold.  Growth inhibition was associated 
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with nitrite production and could be reversed by addition of NMMA to the 
medium (Denis 1991).   
Another study employed an antibody raised to the seven C-terminal amino acid 
sequence of human NOS2 which is absent from human NOS1 and NOS3, as 
well as from mouse NOS2.  Using this antibody, immunocytochemistry was 
performed on bronchoalveolar lavage cells (BLC) from both healthy donors and 
from patients who were culture positive for M. Tuberculosis (Nicholson et al., 
1996).  The results of this study were significant in two ways.  Firstly, NOS2 
was detected in the BLC from all of the TB patients, whereas a much lower 
number of healthy donors had BLC that stained for NOS2.  Secondly, for those 
healthy donors where NOS2 was detected in the BLC, the proportion of BLC 
that stained for NOS2 was markedly lower compared to the proportion of NOS2 
positive BLC from TB patients.  NOS2 expression was also confirmed by 
nested RT-PCR and NO production was detected by cytochemistry in fixed 
sections.  The assay involved the reduction of tetrazolium salts by the NO 
products of the NOS2 enzymatic reaction (Nicholson et al., 1996). 
Another study on M. tuberculosis infection showed that patients with active 
pulmonary tuberculosis had higher levels of exhaled NO compared to healthy 
subjects (Wang et al., 1998).  This correlated with nitrite production from the 
alveolar macrophages cultured from these patients and a higher expression of 
NOS2 in the alveolar macrophages when quantified by flow cytometry (Wang 





1.12.2 The Role of NOS2 and NO production in Dendritic Cells 
Considering that NO plays such an important role in the immune system, and 
since DCs are known to be regulators of the immune system, it is pressing to 
enquire as to what role NOS2 and NO play in the biology of the DC. 
Purified DEC-205 DCs from mouse bone marrow were shown to produce NO 
in a mixed leukocyte reaction (MLR) with allogeneic T cells and upon 
stimulation with IFN-γ and LPS.  The NO production (measured by NO2- in the 
media) was accompanied by an increase in mRNA NOS2 expression and the 
presence of intracellular NOS2 as detected by immunofluorescence and flow 
cytometry in a substantial proportion of the isolated cells (Lu et al., 1996).  
Interestingly, the DCs inhibited the proliferation of allogeneic T cells in a MLR 
and this was attributed to the production of NO.  The authors proposed that DCs 
may play a regulatory role where the NO produced acts in a feedback 
mechanism to modulate the immune response (Lu et al., 1996).   
In another study, it was found that immature DCs that had ingested 
Mycobacterium tuberculosis and were subsequently stimulated with LPS and 
INF-γ inhibited the intracellular growth of M. Tuberculosis but did not actually 
kill the micro-organism (Bodnar et al., 2001).  This contrasted with activated 
macrophages from the same mouse strain which were able to kill the 
mycobacterium through the production of NO.  It was suggested that by 
harbouring live bacteria but restricting its ability to proliferate, DCs could 
maintain immunity by presenting the antigens shed by the micro-organism to 
prime T cells (Bodnar et al., 2001).   
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In maturing mouse DCs, it has been found that there is an increase in the levels 
of NO, which can inactivate caspases and protect important membrane 
trafficking proteins from degradation (Wong et al., 2004).   
NOS2 has been show to bind to li in mouse DCs.  Binding happens at a site 
near the distal di-leucine based sorting signal (Huang, et al., 2008).  The sorting 
motif of li had been identified as a putative caspase cleavage site.  The authors 
concluded that the binding of NOS2 to li may afford protection to li by forming 
a high local concentration of NO which would inactivate the caspases.  
Furthermore, NOS2 was found to interact with li at the ER-like structures and 
endosomal-like structures which represent two regulatory points in the 
intracellular trafficking of li (Huang, et al., 2008).    
The lip35 and lip45 isoforms of human li have shown to contain a di-arginine 
(RXR) ER-retention motif at the N-terminus (Scultze, et al., 1994).  Egress 
from the ER only occurs upon assembly with MHC Class II (Schutze et al. 
1994; Khalil et al., 2003).  In the endosomal compartments, li undergoes 
proteolytic degradation by Cathepsin S. (Bryant et al., 2002).  However in 
immature DCs, the levels of cystatin C (a cathepsin inhibitor) are high, thus 
inhibiting the degradation of li (Pierre and Mellman, 1998).  Since increased 
NO levels concurred with an upregulation of the cell surface expression of 
MHC Class II and the co-stimulatory molecules, Huang and co-workers 
reasoned that protection from caspases may be also an important event in the 





1.13 Concluding Remarks 
It was shown that MHC Class II peptides that have a lower affinity for li can 
bind peptides without proteoloysis of li, and that this can happen earlier in the 
endocytic pathway (Honey et al., 2004).  Hence, controlling the trafficking of li 
may be a way for APCs to selectively sample antigens from a variety of 
compartments. 
Finally the cytoplasmic tail can regulate the migration of DCs after they have 
ingested antigens during maturation (Faure-Andre et al., 2008) so providing a 
way to co-ordinate the migration of the DC with antigen capture and processing 
(Soloff and Barratt-Boyes, 2010). 
Hence an understanding the mechanisms that regulate the trafficking of li is 
central to gain an understanding of the biology of antigen presentation by DCs. 
 
1.14 Objectives of this Study 
(a) To investigate the effect of nitric oxide synthase 2 (NOS2) on the 
trafficking of li 
(b) To study the trafficking upon internalization of li and two mutant 







2.0  Materials and Methods 
2.1  Cell Culture 
2.1.1  Cell lines 
Two cells lines were used in this study.  The cell lines were DC2.4, a mouse 
dendritic cell line, and L2, a rat lung epithelial cell line.   
DC2.4 cell lines were originally derived by transfecting GM-CSF stimulated 
bone marrow cells with retrovirus encoding myc and raf oncogenes.  The 
retrovirus was obtained from the supernatant of NIH J2 Leukemic cells.  These 
dendritic cells expressed a high level of MHC Class II molecules, co-
stimulatory molecules and the characteristic cell marker DEC-205 and were 
able to phagocytose and cross-present antigen (Shen et al., 1997). 
Both cell lines were adherent and cultured in aseptic conditions and grown in 
DMEM media in a humidified incubator at 5% CO2 and at 370C. 
2.1.2  Media for Cell Culture 
The cells lines were cultured in DMEM supplemented with Fetal Bovine Serum. 
Table 2.1  Media for Cell Culture 
Reagent Final Concentration 
Fetal Bovine Serum 10% 
Non-essential amino acids 100 μM (from 10 mM stock) 
HEPES 10mM (from IM stock) 







2.1.3  Propagation of Cell lines 
When the cells became confluent, the culture medium was first removed and 1 
ml of trypsin/EDTA was added to the cells.  The cells were then incubated for 
about 5 minutes at 370C.  When it was observed that the cells started to detach, 
the flask was gently tapped to dislodge the cells and 8 ml of media was added to 
the flask.  The contents were transferred to a 15 ml Falcon Tube and 
centrifuged at 400g for 5 minutes.  The cell pellet was resuspended in cell 
culture media and the cells were seeded at a desired density in new T-75 flasks 
(or bigger flasks if up-scaling was required). 
Generally DC2.4 required sub-culturing every second day, while L2 cells were 
slower growing and required sub-culturing every third day. 
2.1.4 Freezing of Cell lines 
For long term cryostorage, the cells were resuspended to a density of 0.5 - 1 x 
10 cells/ml in cell culture media. DMSO was added to the cell suspension to a 
final concentration of 10%.  The cell suspension was then aliquoted into 
cryogenic vials (Nalge Nunc International A/S, Roskilde, Denmark), frozen at -
800C overnight and transferred to liquid nitrogen for long term storage. 
2.1.5 Cultivation of Cells on Coverslips 
Coverslips (22 mm x 22mm) were washed in 70 % (v/v) ethanol and then 
exposed to UV light for about 30 minutes before use.  A cell suspension was 
prepared and the cells counted and adjusted to a concentration to give an 
approximate 40% confluency by the next day. 
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2.2 Protein Characterization Techniques 
2.2.1 Buffers  
5 x Reducing Buffer 
Tris-HCl pH 6.8 250 mM 
Glycerol  50% (v/v) 
SDS   10% (w/v) 
Bromophenol Blue 0.5M 
 
10x SDS-PAGE Running Buffer 
Tris base  250 mM 
Glycine  2.5 M 
SDS   1% (w/v) 
 
10 x Western Blot Transfer Buffer 
Tris base  250 mM 
Glycine  1.92M 
For 1x Western blot transfer buffer, the 10 x stock buffer is diluted in 7 parts of 
de-ionized water and 2 parts methanol to give a final concentration of 20 % (v/v) 
methanol in the working buffer. 
PBS-Tween 
1 x PBS  
Tween-20  0.05% (v/v) 
 
Western Blot Blocking Buffer and Antibody Diluent 
1 x PBS-Tween 










Table 2.2 Buffers for Immunoprecipitation 
 
Reagent Volume of Reagent for 
Buffer A (ml) 
Volume of Reagent for 
Buffer B (ml) 
0.5M Hepes 0.2  0.2 
1M EDTA 0.2  0.2  
1M DTT 0.01 0.01 
3M KCl 0.33  0.33  
10% (v/v) Triton-X 0.5 0.2 
Deionized water 8.8  9.1 
 
2.2.2 SDS-PAGE 
Protein samples were mixed with 5X reducing Laemmli buffer and incubated at 
950C for 10 minutes to denature the proteins and to allow the SDS to bind. 
After heating the sample, approximately 20 to 45 μl of protein was loaded into 
the well of the stacking gel depending on the size of the comb used.  The gel 
was run at 50V through the stacking gel and at 100V through the resolving gel. 
2.2.3 Western Blot 
After SDS-PAGE, the proteins were transferred to a nitrocellulose membrane 
(Bio-Rad) with the 1 x Western blot transfer buffer at 20V for overnight at 
room temperature.  The membrane was then blocked with blocking buffer at 
room temperature for 1 hour.  The membranes were washed in PBS-Tween for 
3 cycles of 10 minutes each, changing the washing buffer every cycle.  The 
primary antibody was diluted to the required concentration in blocking solution 
and the membrane was incubated in the solution of primary antibody for 2 to 3 
hours at room temperature with gentle agitation.  After the incubation, three 10 
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minute wash cycles with PBS-Tween were carried out and the membrane was 
then incubated with the conjugated secondary antibody diluted in blocking 
buffer for 1 hour at room temperature.  After the incubation, 3 wash cycles were 
performed as before.  Proteins were visualized using the Pierce 
Chemiluminescent kit.  
2.2.4  Immunoprecipitation 
2.2.4.1  Cell lysis 
Media was removed from the petri-dishes or flasks and rinsed twice with PBS 
that had been kept at room temperature in order to remove dead cells.  The cells 
were covered completely with a small amount of cold lysis buffer.  When the 
cells detached, the petri-dish or flasks were rinsed thoroughly with 
approximately 500μl of cold lysis buffer and the contents were transferred to an 
eppendorf tube on ice.  The cells were incubated for 1 to 2 hr on ice with 
periodic mixing of contents every 10 to 15 minutes.  Cell debris was pelleted by 
centrifugation at 10,000 g for 20 minutes in an Eppendorf centrifuge, at 4°C. 
 
Table 2.3 Cell Lysis Buffer 
 
The reagents listed in the table below are dissolved in phosphate buffered saline 
(PBS) 
Reagent Final Concentration 
Triton-X 1 % (v/v) 
Protease Inhibitors 1 x strength* 
PMSF 2mM 
* Complete EDTA free Easy Pack (Roche) 
1 tablet is dissolved in 2 ml of water (makes a solution of 25 x strength). 
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2.2.4.2  Immunoprecipitation 
The cell lysate were aliquoted in the appropriate proportions for mixing with 
each of the antibodies to be used.  Approximately 0.5mg to 1 mg of total 
protein lysate was used for each antibody sample.  An equal volume of diluting 
buffer was added to each of the cell lysate aliquots and mixed gently.  Each of 
the cell lysate aliquots were added to one of the antibody-bound Protein G 
Sepharose bead preparations and mixed gently by tapping the tube and 
inverting it a few times.  It was then incubated in the cold room overnight on a 
rotating wheel.  The bead/cell lysate suspension was centrifuged in an 
Eppendorf 5415R centrifuge, at 600g, for 5 minutes, at 4°C.  The bead/cell 
lysate suspension was washed three times with cold wash buffer A.  This was 
done by centrifuging the beads in 1 ml of cold buffer A, centrifuging at 600 g 
for 5 minutes in an Eppendorf 5415R centrifuge, at 4°C, and removing the 
supernatant.  The protein G bead/cell lysate suspension was then washed three 
times in wash buffer B.  After the final wash, the beads were re-suspended in 60 
μl 1X SDS-reducing buffer and boiled for 10 minutes.  The beads were 
collected by centrifugation in an eppendorf centrifuge and SDS-PAGE was 









2.3 Subcellular Fractionation 
 
Subcellular fractionation was performed as described (Antebi and Fink, 1992) 
with modifications. 
There were two parts to the procedure:  
• Homogenization  
• Sub-cellular fractionation. 
Solutions Required 
• 2M Sucrose solution (68.46g sucrose dissolved to a final volume of 
100ml in Milli-Q water) 
 
• Homogenization buffer (12.5% Sucrose; 10mM Hepes buffer; 1mM 
EDTA; 1mM PMSF) 
 
• Sucrose solutions (18% (w/v) to 54% (w/v) sucrose in 4% increments.  
Each sucrose solution contains 10mM Hepes buffer; 1mM MgCl2 and 
1mM PMSF  
 
• PMSF (Phenylmethylsulfonylflouride: SIGMA) 
 
• Protein inhibitor cocktail tablets, complete EDTA free (Roche) 
 
• 2mM EDTA in PBS 
2.3.1  Homogenization 
Media was removed from cell flasks and rinsed twice with PBS that had been 
kept at room temperature in order to remove dead cells.  Eight ml of 2mM 
EDTA/PBS (equilibrated to 370C) was added to each flask ensuring that the 




The flasks were incubated at 370C in the 5% CO2 humidified incubator for 15 to 
30 minutes (or until the cells started to detach).  The flasks were then tapped 
firmly to dislodge the remaining cells.  Cells were collected and the inside 
surfaces of the flasks were washed with more PBS.  
The suspension was transferred to a Dounce homogenizer and the cells were 
subjected to 12 strokes of homogenization.  The cells were checked with trypan 
blue to ensure that the nuclei were still intact.  Cells were homogenized until 
about 80% of the cells were lysed.  At all times the volume of the buffer was 
kept below 1ml.  Lysates were then centrifuged (6000g, in an Eppendorf 
centrifuge, for 20 minutes, at 40C).  The supernatants were then centrifuged in 
an Optima Max-XP ultracentrifuge at 10,000g 15 minutes at 40C.  This 
supernatant should contain intact Golgi and endoplasmic reticulum enriched 
fractions.  After centrifuging, the samples are kept on ice. 
2.3.2  Subcellular Fractionation 
In a Beckman P-A (14 x 95mm) tube, a 9-step discontinuous sucrose gradient 
was prepared of 1.1ml sucrose concentrations ranging from 54% (w/v) sucrose 
(the bottom layer) to 18% (w/v) sucrose (the top layer) with increments of 4% 
sucrose concentrations. 
The cell lysate was overlaid carefully on top of the sucrose gradient and the 
tube was centrifuged at 175,000g (in a Hitachi Centrifuge) for 2.5 hours at 40C.  
Fractions of 0.77ml were collected sequentially from the top of the gradient to 
the bottom.  Lysis buffer was added to each of the fractions and incubated on 
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ice for 1 to 2 hours with periodic mixing of the tube contents every 10 to 15 
minutes.  Following lysis the fractions were stored at -800C until needed. 
2.4  Immunoflouresence 
2.4.1 Intracellular Staining 
Cells were grown on coverslips and fixed either in methanol at -200C for 4 
minutes or in 4% (v/v) paraformaldehyde for 30 minutes.  If fixing was done 
with paraformaldehyde the cells were then washed four times with 0.1% (w/v) 
saponin and then incubated with 0.1% (w/v) saponin in order to permeabilize 
the cells.  After permeabilization, primary antibodies (diluted in PBS containing 
5% (v/v) goat serum) were added and the cells incubated for 1 hour at room 
temperature.  The cells were then washed four times in 0.1% (w/v) saponin and 
the secondary conjugated antibody was added and incubated for 1 hour at room 
temperature protected from light.  After the incubation the cells were washed 
four times with 0.1% saponin and mounted on a glass slide containing DAPI 
and an anti-fading agent.  Cells were viewed under a microscope or with the 
confocal. 
If methanol is used as a fixing agent, washes are performed in PBS and there is 
no need of a permeabilization step as methanol also permeabilizes the cells.  
2.4.2 Staining for Internalization 
Cells were incubated with primary antibodies on ice for one .hour. After the 
incubation, the cells were washed once in ice-cold PBS and then in ice cold 
media to remove cell debris.  The cells were transferred to 370C humidified 
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incubator for a specified time interval.  After the incubation cells were fixed 
with 4% (w/v) paraformaldehyde or methanol as mentioned above. 
After washing with 0.1 % saponin another primary antibody is added if double-
labelling is to be performed and the cells are incubated for 1 hour at room 
temperature followed by washing.  If only single staining is required, cells are 
incubated with a conjugated secondary antibody for 1 hour at room temperature 
(protected from light).  After the secondary antibody incubation step, the cells 
are washed and mounted on coverslips witho\ a solution containing DAPI.  The 
cells were viewed under a fluorescent microscope or with confocal microscopy. 
We used methanol fixation when only one primary antibody was used and 4% 
paraformaldehyde fixation for double-labelling. 
 
2.5 Transfection 
Two different kinds of transfections were performed using: 
• Lipofectamine 









2.5.1 Transfection using Effectene 
Transfection was performed for cells in 6-well tissue culture plates.  The 























0.4 3.2 100 10 1600 600 
 
Before the transfection, the old media was removed from the cells, and each of 
the wells was washed once with sterile PBS.  Pre-warmed media at the 
specified volume was added and the cells were returned to the humidifier. 
The transaction was performed in FACS tubes under aseptic conditions in the 
laminar flow hood.  The DNA and EC buffer were mixed to a total volume of 
100μl/well of a 6-well tissue culture plate.  Enhancer was added and all 
contents were mixed by pipetting gently up and down four times followed by 
incubation for 5 minutes at room temperature.  After the incubation effectene 
was added and mixing was carried out as before.  The mixture was then 
incubated for 10 minutes at room temperature.  After the incubation the 
specified volume of media was added with gentle mixing by pipetting up and 
down.  The mixture was then added drop wise to the cells and the plate rocked 
gently and moved in a circular motion to mix the contents in the wells evenly.  




For experiments where co-transfection with NOS2 was performed, the total 
amount of DNA that added was 1.2μg per well, in the proportion of li: NOS2 
(1:2).  The amount of enhancer added was then 6.8μl to keep the ratio (1:8) 
between DNA and enhancer.  The amount of EC buffer was adjusted to keep 
the final volume constant. 
2.5.2 Transfection using Lipofectamine 
 
Transfection was performed in the laminar flow hood on DC2.4 cells in 10 cm 
diameter tissue culture plates.  
Before the transfection, DMEM media was removed from the cells and replaced 
with OPTIMEM medium. 
In one tube, DNA (24μg) was added to 1.5 ml OPTIMEM and in a separate 
tube Lipofectamine (60μl) was added to 1.5 ml Lipofectamine.  The DNA was 
then mixed with the Lipofectamine solution and incubated for 5 minutes at 
room temperature.  The mixture was then added to the cells and the cells placed 
in the 5% CO2 incubator for 6 hours before the OPTIMEM containing the 
lipofectamine was removed and replaced by DMEM.  The cells were incubated 










3.0  Results 
Part 1 Effect of Nitric Oxide Synthase 2 on the Trafficking of li 
3.1 Effect of NOS2 on the intracellular distribution of li 
Recently Huang and co-workers showed that in mouse DCs NOS2 can interact 
with li (Huang et al., 2008).  Substituting Asp 6 with alanine by point mutation 
(D6A) abolished binding of NOS2 to li and strongly suggested that the NOS2 
binding site is located at a region very close to the membrane distal di-leucine 
based motif.  Interestingly, the authors found that the DQRD sequence of the 
di-leucine based motif is also a putative caspase cleavage site, and indeed the 
D6A mutation rendered li resistant to caspase-4 cleavage (Huang et al., 2008).  
The authors proposed that a high local concentration of NO produced by NOS2 
binding near the casapse cleavage site could protect li from caspase-4 cleavage 
(Huang et al., 2008) possibly through S-nitrosylation of the caspase catalytic 
sites.  Furthermore confocal images revealed that the interaction of li and NOS2 
occured at endosomal-like structures and at the endoplasmic reticulum (ER)-
like region (Huang et al., 2008).  Since caspase -4 was also found to localize to 
the ER membrane it led Huang and co-workers to suggest that it would be 
imperative that li is protected from degradation at the period when li is 
assembled and inserted in the endoplasmic reticulum.  Furthermore, the 
endosomal compartments is where li undergoes proteolytic cleavage to CLIP 
(Matza et al., 2003; van Niel et al., 2008).  Hence it seems that NOS2 interacted 
with li at important positions along its intracelluar route to the endosomal 
structures.  Since in conditions of high NOS2 expression as is found in 
stimulated DCs (Wong et al., 2004) there is an upregulation of many important 
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trafficking proteins , we wanted to investigate whether conditions of high NOS 
expression can affect the intracellular distribution of li. 
L2 cells were used for these experiments because they are not known to express 
endogenous li and so would be a ‘clean’ system without contribution from 
endogenous li.  Furthermore, the relatively large size of these cells lends itself 
well to study the intracellular structures. 
L2 cells were co-transfected with a plasmid construct of the p31 isoform of 
mouse li containing a pDMyc tag (pDmyc-li) and a plasmid construct of NOS 2 
(pNOS).  Triple-label staining was performed for li, NOS2 and endogenous 
LAMP1 and analysed by confocal microscopy.   
As seen in figure 3.1, in conditions of high NOS2 expression (shown by the 
green arrows, panel a), li was confined to the perinuclear region (green arrows, 
panel b).  By contrast, when NOS2 expression levels were low or negligible 
(purple arrows, panel a), the staining for pattern li showed a peripheral 
distribution and an increased presence of punctate structures (purple arrows, 
panel b).  In previous published work, Bakke and Dobberstein used electron 
microscopy and fluid phase markers to identify the punctate 





Figure 3.1  Triple-labelling for li, NOS2 and LAMP1.  
L2 cells were transfected with the pDMyc-li construct and the plasmid NOS2 construct 
(pNOS).  The cells were incubated with goat anti-c-Myc, monoclonal mouse anti-
NOS2 and rabbit anti-LAMP1.  Cells were visualized by FITC-conjugated donkey 
anti-goat IgG to detect li (shown by the green staining), cy3-conjugated donkey anti-
rabbit IgG to detect LAMP1 (red staining) and Alexa Fluor 488 conjugated donkey 
anti-mouse IgG to detect NOS2 (blue staining).  The green arrows (panels a, b) show 
high NOS2 expression and confined perinuclear staining of li (panel b); purple arrows 
(panels a, b) show low NOS2 expression and punctuate structures of li staining (panel 
b); white arrows show co-localization between li and NOS2 (panel d); yellow arrow 
shows partial co-localization between li and LAMP1 (panel e).  Image, Olympus 
confocal, magnification, 100X. Bar, 5µm.  The figures are representative of four 
independent experiments.  
 
The diminished staining of LAMP1 under conditions of high NOS2 expression 
shows that the effects of high NOS2 expression are not limited only to li.  This 
is expected since the widespread interaction of NO with many proteins and 
molecules in the cell can affect intracellular signalling pathways and the 
transcription of many genes (Bogdan, 2001).  
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However, it is of interest to note that a higher degree of co-localization between 
li and NOS2 (white arrows, panel d) seemed to correspond to a more prominent 
perinuclear staining implying that this effect was dose dependent on the 
concentration of NOS2. 
As well as wanting to investigate whether high NOS2 expression would affect 
the intracellular staining pattern of li, we also wanted to assess whether this 
change would reflect a change in co-localization with endosomal markers.  
Since li was shown to traffic to the late endosomes/lysosomes in steady state 
(Pieters et al., 1993) we used LAMP1 (a marker for late endosomes/lysosomes) 
as a marker for co-localization (Loss and Sant, 1993). 
If NOS2 has the effect of retaining li in the perinuclear under conditions of high 
NOS2 expression, we would expect to see less co-localization with LAMP1 
compared to conditions where NOS2 is absent.  In conditions where NOS2 is 
absent li would show normal steady state distribution and a higher degree of co-
localization with LAMP1.  
As seen in figure 3.1(panel e, yellow arrows), li showed partial to co-
localization with LAMP1 and agreed with other past published findings (Pieters, 
et al., 1993).  It is noteworthy that co-localization with LAMP1 happened on 
the peripheral sections of the LAMP1 positive vesicles.  The clusters of 
LAMP1 positive vesicles in the centre did not show any co-localization.  This 
may reflect a higher density of LAMP1 structures, and compartments that are 
later in the endocytic route.  Ii undergoes proteolysis in the late 
endosomal/lysosomal compartments (Byrant, et al., 2002). 
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The concentration of NOS2 did not seem to affect the degree of co-localization 
with LAMP1.  There was no detectable difference in co-localization of li with 
LAMP1 in cells with high or negligible NOS 2 expression (panel e).  This may 
reflect the difficulty in observing subtle changes in distribution of li at steady 
state conditions at a particular intracellular location, even though there seemed 
to be fewer punctate structures overall under conditions of high NOS2.  
Staining at steady state conditions would represent a snap shot of li at various 
locations inside the cell.  This means that the total number of endosomal 
structures is seen, including LAMP1 positive structures.  Under such conditions 
a pool of li molecules would be continually arriving at the late endosomal 
compartments while degradration of Ii in those compartments is also taking 
place.    
Since however, we did observe a more confined perinuclear staining of li under 
high NOS2 expression, we attempted to quantify using subcellular fractionation 
the amount of li in the ER and the post-Golgi organelles.  
DC2.4 cells were used in these experiments because they express endogenous li.  
DC2.4 cells were transfected with pNOS or a vector control.  After 24 hours the 
cells were homogenized and the nuclear-free lysate was subjected to subcellular 
fractionation using a methodology adapted from Antebi and Fink (Antebi and 
Fink, 1992).  Briefly the nuclear-free lysate was layered on top of a 9-step 
sucrose density gradient and then was subjected to high speed centrifugation in 
order to resolve the subcellular components along the sucrose gradient 
according to their densities.  In this system the rough endoplasmic reticulum, 
being of high density, will stop sedimenting in regions of high sucrose density 
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towards the bottom of the tube, while the endosomal structures, since they are 
less dense, will reach an equilibrium density position in regions of low sucrose 
density towards the top of the gradient.  After the ultracentrifugation step equal 
volumes of fractions were aspirated from the top of the gradient and each 
fraction was analysed by SDS-PAGE and Western blot.  The fractions were 
probed with antibodies to li, and the distribution of li across the membrane 
fractions was assessed using LAMP 1 (to detect the late endosomal-enriched 
fractions) and calrecticulin (a protein found in the ER) as markers.  
As seen in figure 3.2A and figure 3.2C, two peaks were identified using 
LAMP1 and calrecticulin as markers, which correspond to endosomal-enriched 
fractions and ER-enriched fractions respectively.  For both the vector control 
and the NOS2 transfected cells, lip31 (the dominant isoform in mice) was found 
to be present in both the endosomal-enriched and the ER-enriched fractions 
reflecting steady state conditions (Figures 3.2A and C and corresponding 
western blots).  However, there appeared to be a difference in the distribution of 
lip31 between these two fractions in the vector control compared to the NOS2 
transfected cells.  In the vector control (figures 3.2 A and B), lip31 was more 
evenly distributed, with peaks seen in both the endosomal-enriched fractions 
and the ER-enriched fractions whereas in the NOS2 transfected cells (figures 
3.2C and D), there seemed to be a shift in the distribution of li towards the ER-































































































Figure 3.2 Subcellular fractions on DC2.4 lysates. 
 
NOS2 transfected DC2.4 cells and vector control cells were lysed, and the nuclear-free 
fraction was layered on a sucrose density gradient as described in the materials and 
methods.  After the separation, individual fractions were analysed by SDS-PAGE and 
probed with a rat monoclonal antibody to li (In-1), a rat polyclonal antibody to LAMP1 
and rabbit anti-calrecticulin followed by horseradish peroxidase conjugated secondary 
antibodies against each of the respective species of primary antibodies.  Probing for li, 
LAMP1 and calrecticulin was done separately by cutting the respective strips 
corresponding to these samples.  The bands were visualized by ECL and the intensity 
of each band was assessed by the Image J software. (A) Graph of the subcellular 
fractionation for the vector control.  (B) Corresponding Western blot for the vector 
control.  (C) Graph of the subcellular fractionation for NOS2 transfected DC2.4 cells.  
(D) Corresponding Western blot for the NOS2 transfected cells.   
 
 
The difference in the distribution of li is more marked if both isoforms of li are 
taken into account.  In this case, the majority of li in the vector control peaks in 
the endosomal-enriched fractions (figures 3.2A and B), which means there is 
relatively more lip41 located in these fractions compared to the ER-enriched 
fractions.  The converse seems to be true for the NOS2 transfected cells where 
more of the lip41 is found in the ER-enriched fractions (figures 3.2C and D).   
These results suggest that under high NOS2 expression the distribution of li is 
inclined towards the ER region.  Taking these results together with the IF data 
(figure 3.1) would indicate that the distribution of li towards the ER is 
influenced by NOS2 binding to li.  
 
3.2 γ-adaptin showed partial co-localization to the perinuclear region 
Huang and co-workers found that NOS2 can bind to a region very near the 
distal di-leucine based motif (Huang et al., 2008).  This raises the question of 
whether the attachment of NOS2 to li can block the accessibility to adaptor 
proteins.  Since we found that NOS2 binding to li confines it to the perinuclear 
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region, we wanted to investigate further the relation of AP-1 binding to li with 
regards to the location inside the cell.  Binding of AP-1 to li in the perinuclear 
region was first shown by Salamero and co-workers (Salamero, et al., 1996).  
The perinuclear region most likely was the Golgi region since AP-1 is known to 
traffick from the Golgi to the endosomal compartments (Robinson and 
Bonifacino, 2001).  However a marker was not used to identify that region in 
that study.  Since it was found that NOS2 interacts with li at the ER-like region 
(Huang et al., 2008), and the gradient subcellular fractionation revealed that a 
substantial proportion of li is present in the ER-enriched compartments even at 
steady state, we at first wanted to establish the interaction of li with AP-1 in 
relation to the ER-like region. 
L2 cells were co-transfected with the plasmid construct of the pDMyc-li and 
triple-label staining was performed for li, calreticulin and γ-adaptin and 
analyzed by confocal microscopy.   
As shown in figure 3.3, co-localization is evident for li and γ-adaptin and for li 
and calreticulin.  This is expected because γ-adaptin is distributed in the 
cytoplasm as part of the AP-1 complex and regulates trafficking from the Golgi 
to the endosomal compartments (Robinson, 2004).  Partial co-localization with 
calrecticulin suggests that li is partly in the ER, which would be consistent with 
the subcellular fractionation data.  Surprisingly, at a particular co-localization 
region of li with calrecticulin, partial co-localization is seen with γ-adaptin as 
well.  This is unexpected because AP-1 is known to function at the trans-Golgi 
network “TGN” (Robinson, 2004) and any association of AP-1 at the ER region 
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would be novel.  However, we suspect from the IF data that there may be some 
kind of involvement of AP-1 in the ER region as well.  
 
3.3 Co-immunoprecipitation of γ-adaptin and li 
Binding of li to the motif of AP-1 has been demonstrated by surface plasmon 
resonance (Hofmann et al., 1999) and by immunoprecipitation where peptides 
of the cytoplasmic tail of li were attached to beads as ligands (Rodionov and 
Bakke, 1998; Dietrich et al., 1997).  However, an in vitro binding assay may not 
necessarily mean that binding happens in the cell.  An in vitro assay uses a high 
concentration of li as ligands but in vivo the concentration of binding partners 
may be low.  
Furthermore, some studies stated that sorting of li to the endosomes is 
independent of AP-1 (Glickman et al., 1996; Liu et al., 1998) and that AP-2 
plays the major role in the sorting of li (Dugast, 2005). 
Since we found evidence of partial co-localization of γ-adaptin with li and 
calreticulin, we wanted to investigate by co-immunoprecipitation whether there 
is any interaction between li and AP-1 and AP-2 respectively in the cell. 
For these experiments, DC2.4 cells were transfected with the pDMyc-li 
construct.  Lysates were prepared and split into four samples.  The samples 
were incubated with a monoclonal antibody (mAb) to either γ-adaptin or α-
adaptin and the corresponding isotype control which was mouse IgG.  
Immunoprecipitation was performed with Sepharose G beads.  The 
immunoprecipitated (IP) samples and isotype controls were resolved on SDS-
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PAGE and western blots were performed.  The blots were then cut up to probe 
for the adaptins and li separately.  In each case, the adaptins were probed with 
the respective antibodies directed against these proteins and a rat monoclonal 
antibody to the cytoplasmic tail of li (In-1) was used to probe for li. 
Figure 3.3 
 
Figure 3.3 Triple-labelling for li, γ-adaptin and calreticulin. 
L2 cells were transfected with the pDMyc-li construct.  The cells were incubated with 
goat anti-c-Myc, monoclonal mouse anti-γ-adaptin and rabbit anti- calreticulin.  Cells 
were visualized by FITC-conjugated donkey anti-goat IgG (green, to detect li), cy3-
conjugated donkey anti-rabbit IgG (red, to detect calreticulin) and Alexa Fluor 488 -
conjugated donkey anti-mouse IgG (shown in blue, to detect γ-adaptin).  Co-
localization is shown by the white arrow for li and γ-adaptin (bottom left panel), yellow 
arrow for li and calreticulin (bottom middle panel), and partial co-localization is shown 
by magenta arrow for γ-adaptin and calreticulin (bottom right panel).  Image, Olympus 
confocal, magnification, 100X.  Bar, 5µm.  The figures are representative of three 










































Figure 3.4 Co-Immunoprecipitation of li.  
Cell lysis was performed on confluent DC2.4 cells.  Immunoprecipitation was 
performed as described in the Materials and Methods section.  For each case, IP was 
performed using either a monoclonal antibody to γ-adaptin or to α-adaptin. . The 
amount of whole cell lysate is indicated for each case as well as the amount of 
immunoprecipitated (IP) sample loaded in the gel.  Approximately the same amount of 
the γ-adaptin isotype control as for the γ-adaptin IP sample was loaded on the SDS-
PAGE gel.  This was also the case for the α-adaptin isotype control where 
approximately the same amount as the α-adaptin IP sample was loaded on the SDS-
PAGE gel.  The first well on the left is the monoclonal antibody that was used in the 
assay.  The isotype control used was whole mouse IgG.  The western blot strip was cut 
out into sections and stained with the appropriate antibodies.  One strip of the whole 
cell lysates and another of the IP samples were each probed with In-I (a rat monoclonal 
antibody against mouse li) to detect li and another strip was probed with monoclonal 
antibodies against either γ-adaptin or α-adaptin to detect the adaptins followed by 
horseradish peroxidase conjugated secondary antibodies against each of the respective 
species of primary antibodies.  The bands were visualized using ECL. (A) 
Immunoprecipitation was performed with a monoclonal antibody to γ-adaptin.  The 
p31 li chain in the IP sample is indicated by the red marker.  (B) Immunoprecipitation 
was performed with a monoclonal antibody to α-adaptin.  The p31 li chain in the lysate 
is indicated by the black marker.  No li was detected in the IP sample. 
 
As shown in figure 3.4A for the γ-adaptin IP a substantial amount of γ-adaptin 
was precipitated.  In addition, a distinct band corresponding to li was detected 
with In-1 in the IP sample which was not visible in the isotype control.  This 
same band was also detected in the whole cell lyates further substantiating that 
the band did correspond to li.  Notably a substantial amount of IP sample was 
required to visualize the li band.  This is expected since γ-adaptins are present 
in abundance and interact with many other proteins.  Furthermore, the 





















(C)  DC2.4 lysates were transfected with a li construct with an N-terminal pDMyc tag 
(pDMyc-li) or a c-Myc vector control.  Immunoprecipitation was performed using 
rabbit anti-c-Myc antibody.  The western blot was probed with In-1 and with a 
monoclonal antibody to γ-adaptin.  The lip31 invariant chain and the pDmyc-li 
construct of li are shown by the red markers.  
 
The isotype antibody was a mixture of both the gamma and kappa light chains.  
A faint band is present in the isotype light chain corresponding to the light 
chain of the anti- γ-adaptin monoclonal antibody (mAb).  This occurred because 
the horseradish peroxidase conjugated antibody to detect rat IgG cross-reacted 
with the mouse mAb that was used in the immunoprecipitation assay.  This 
shows that the mAb anti- γ-adaptin most likely contains the minor form of the 





Since the molecular weights of li and the light chain of the antibody used in the 
pull down were almost similar, we also analysed the mAb anti- γ-adaptin on the 
western blot to ensure that the band obtained for li is not an artefact of the 
antibody itself.  Gaps were left between the samples to guard against any 
potential leakage.  When probed by Western blot, the mouse mAb did not show 
any bands that corresponded to that identified in the IP using In-1.  Thus there 
is a high probability that the band detected with In-1 does indeed correspond to 
li. 
Regarding the co-immunoprecipitation assay for li using an antibody against α-
adaptin, no li could be obtained (see figure 3.4B).  The bands in the supposedly 
empty lanes was due to some leakage occurring.  There is no discernible 
difference between the IP sample using the anti-α-adaptin antibody and the 
isoptype control.  One possibility for this may be that the mAb used against α-
adaptin binds with a low affinity.  The other possibility is that α-adaptin binds 
to li with a much weaker affinity (Hofmann et al., 1999) compared to γ-
adaptins binding to li.  As noted in the IP sample, α-adaptin was present at 
levels not that much greater than the isotype control and the difference is not as 
marked as that for the γ-adaptin IP. 
When we tried to immunoprecipitate γ-adaptin by using the monoclonal 
antibody against li, we found that even though a substantial amount of li could 
be immunoprecipitated, no γ-adaptin was detected in the IP sample.  We 
reasoned that since In-1 binds to the cytoplasmic tail of li, it may interfere with 
the binding of γ-adaptin to the di-leucine based motif and what was being 
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pulled down was probably the li chain that was not bound to the adaptin.  Hence 
we changed strategy and checked for li as a binding partner to γ-adaptin instead. 
In order to get around the potential problem that In-1 may be blocking the 
adaptins from binding, we decided to peform an immunoprecipitation on li that 
is tagged with c-Myc at the N-terminus.  DC2.4 cells were transfected with the 
pDMyc-li construct or with the c-Myc vector control.  Lysates were prepared 
and in each case a rabbit antibody to c-Myc was used to perform the 
immunoprecipitation.  As shown in figure 3.4C, a significant proportion of 
pDMyc-li was present in the IP samples compared to the vector control.  
However a faint band corresponding to γ-adaptin was present in both the IP 
sample and the vector control.  Since a monoclonal antibody was used to probe 
for γ-adaptin, the band is not likely to be a nonspecific protein.  The small 
amount obtained probably reflects non-specific binding to the rabbit IgG 
antibody that was used in the immunoprecipitation.  The reason that no 
significant amount of γ-adaptin was obtained is probably because we are 
targeting only the plasmid construct of li, and the amounts may not be sufficient 
to detect any interaction with γ-adaptin.  
 
3.4 Conclusion I 
At high NOS2 expression, there was evidence for a change in the intracellular 
distribution of li with indications that it was confined to the nuclear region.  
This was also supported by subcellular fractionation which suggested that a 
greater proportion of li was located in the ER-enriched fractions under 
conditions of NOS2 overexpression.  Taken together with previous findings that 
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the NOS2 can interact with li gave rise to the hypothesis that binding of NOS2 
may be affecting the intracellular distribution of li.  Since NOS2 binds very 
close to the distal di-leucine based motif, it raises the question of whether it 
may function to prevent the binding of AP-1.  Surprisingly, γ-adaptin was found 
to partially co-localize to calreticulin at the same region where partial co-
localization with li was noted suggesting a possible involvement of AP-1 in the 
ER-like region.  Intracellular interaction between li and γ-adaptin was 
confirmed by co-immunoprecipitation of li with γ-adaptin. 
 
Part II Internalization of li from the Plasma Membrane 
3.5 Mutant constructs internalize faster compared to the wild type li 
Various findings have shown that deleting the cytoplasmic tail region 
containing both of the leucine-based sorting motifs results in an accumulation 
of li on the cell surface (Bremnes et al.1990; Pieters, et al., 1993).  Furthermore, 
various studies have identified Asp2 and Asp3 in addition to Leu7 and Leu16 as 
being very important for internalization.  Mutations of any of these amino acids 
to alanine either abolished or slowed down internalization (Pond et al., 1995).   
It is also worthwhile to note that previous published work on the 
characterization of the DXXXLI sorting signal of li has been carried out in the 
context of only one functioning leucine-based pair.  The reason for this is to 
attribute any observed effect to that one functioning motif without interference 
from the other.  However, there is evidence that key amino acids are recognized 
by binding proteins within the structural context of the whole motif.  So when 
Pond and co-workers replaced the DQRDLI motif with the DXXXLI motif 
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from other proteins, mutation of the crucial amino acids did not affect 
internalization of li (Pond et al., 1995).  This raises the question of whether the 
DXXXLI motifs in the cytoplasmic tail of li are also read in one whole 
structural context, even though they can function independently of one another.  
Hence we wanted to find out whether mutating or deleting certain amino acids 
of the DXXXLI motif would have any effect on the trafficking of li when both 
di-leucine based signals are present. 
Three constructs that were previously prepared in the lab were used for this 
work.  The constructs consisted of the p31 isoform of wild-type mouse li (c-
Myc-li-FLAG) and two mutant constructs.  One had an alanine substitution for 
aspartate at position 6 (c-Myc-D6A-FLAG); the other construct was a truncated 
mutant that lacked the first six amino acids (c-Myc-liΔ6-FLAG).  Each 
construct was cloned in a c-myc vector and had a Flag tag at the C-terminus 
(see figure 3.5).  
 
Figure 3.5  Mutant constructs of mouse p31 isoform of li.  One mutant construct 
had an alanine substitution at amino acid residue 6; the other lacked the first N terminal 
amino acids.  The constructs are denoted as follows: for wild type li (c-Myc-li-FLAG, 
abbreviated as liWT), for the alanine substituted mutant (c-Myc-D6A-FLAG, 




The truncated mutant lacked the acidic amino acids which were found to be 
critical for internalization in the context of Leu7/Ile8 pair.  While the D6A 
mutation in the wild type li rendered it unable to bind NOS2 (showing that there 
were structural differences to wild type li), it did not seem to affect 
internalization (Pond et al., 1995), making this construct suitable for use as a 
kind of control.  
L2 cells were used for these experiments because as previously explained they 
are not known to express endogenous li and are suitable for viewing 
intracellular structures clearly.  Methanol fixation was used for this segment of 
the study because it was found to give a more distinct and clear staining of the 
intracellular structures compared to paraformaldehyde. 
In order to study the endocytosis of li and the mutant constructs, 
immunofluorescence (IF) was performed on L2 cells that were transiently 
transfected with one of the constructs shown in figure 3.5 above.  Briefly, cells 
were incubated on ice for 1 hour with a monoclonal antibody against the FLAG 
tag.  The cells were then chased in media alone for the indicated time periods 
and stained with a secondary antibody. 
As seen in figure 3.6 A, at the 0-minute and at the 5-minute time-points, the 
wild type li (liWT) and truncated li (liΔ6) appeared on the cell surface as 
diffuse staining with sharp boundaries.  However, at 5 minutes very small 
punctate structures (shown by the white arrows) for both liWT and liΔ6 began 
to appear.  This indicated the beginning of endocytosis.  These structures 
became more distinct at the 10-minute time-point.  In both cases liΔ6 showed a 
79 
 
greater number of these structures compared to liWT.  As seen by the graph in 
figure 3.6C, this corresponded to a faster internalization rate for liΔ6.   
At 15 minutes the punctuate structures became more prominent and dispersed 
throughout the cytoplasm with a greater number of these structures being more 
evident in the liWT transfected cells.  In both cases however, the numbers of 
these dispersed punctuate structures seemed to reach a plateau (see figures 3.6C) 
as the punctuate structures seemed to assemble into small structures that had a 
vesicular-like appearance (figure 3.6A, yellow arrows and graph of figure 3.6D).  
For the purpose of this description, we will define these structures that have a 
‘tyre-like’ morphology as vesicular-like structures and the smaller distinct ‘dots’ 
as punctate structures.  This definition does not in any way mean to imply that 
the small dots are not themselves very small vesicles, but that based on 
appearance alone they do not resemble the ‘tyre-like’ structures.  These small 
punctate structures are most likely to resemble early endosomal compartments.  
The larger ‘tyre-like’ structures would correspond to later endosomal 
compartments.    
By 20 minutes the very small vesicular-like structures (shown by the yellow 
arrows) became more defined in both the liWT and the liΔ6 transfected cells 
with li∆6 showing a significantly greater proportion of these (see figure 3.6D).   
At 30 minutes these vesicular-like structures gained a more distinct morphology 
for both liWT and liΔ6 and there was no discernible difference in the 
proportions between liWT and liΔ6.  This pattern continued into 60 minutes 
(figure 3.6A).  At this time point the number of these vesicular-like structures 
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was significantly greater in the liWT transfected cells (figure 3.6D).  By 180 
minutes, the staining resembled a more ‘sandy’ appearance with very small 
structures throughout the cytoplasm as the vesicular-like structures changed 
into small dot-like structures (figure 3.6A). 
Comparing the liWT and the liD6A mutant (see figure 3.6B), there was diffuse 
surface staining at both 0 minutes and 5 minutes but the early stages of 
endocytosis were already evident with the appearance of small punctuate 
structures beneath the peripheral membrane.  At the 10-minute time-point the 
number of punctuate structures increased for both liDA6 and to a lesser extent 
liWT as liDA6 seemed to internalize at a faster rate as (figure 3.6B and figure 
3.6E).  At 15 minutes however the number of punctate structures for the liD6A 
showed signs of stabilizing and the liWT transfected cells showed a greater 
number of the punctate structures (figure 3.6E).  Clustering of punctuate 
structures towards a vesicular-like arrangement was noted being more 
prominent for liD6A (see figure 3.6B for the appearance of these vesicular-like 
structures and figures 3.6F for the proportion of these vesicular-like structures).  
By 20 minutes the numbers of the small distinct punctate structures began to 
stabilize for the liWT as well and the peripheral boundary seen in the earlier 
time-points was no longer present for both the liWT and the liD6A.  At 20 
minutes, more of the punctate structures clustered into vesicular-like 
arrangements with liDA6 still displaying significantly greater numbers.  By 30 
minutes, the vesicular-like structures became better defined and there was no 
discernible difference in the proportions of these between liWT and liD6A 
(figures 3.6F).  This staining pattern continued into the 60 minute time-point.  
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At 180 minutes, it appeared that the boundaries of these vesicular-like 
structures had disintegrated to give rise to a more ‘sandy’ appearance present 
throughout the cytoplasm.   
These results reveal distinct stages in the internalization of li and the mutants as 
assessed by the morphology of the structures.  The early stage of endocytosis 
was evident at 5 minutes.  In both cases, the mutants seemed to internalize more 
rapidly compared to the wild type li.  At 15 minutes most of the surface liWT 
and mutants had been internalized and started to assemble into vesicular-like 
structures that had a ‘tyre-like’ appearance.  These looked different to the 
punctate structures that resembled distinct dots.  The next change began to 
occur at 20 minutes where the small vesicular-like structures became better 
defined and gained a distinct morphology by 30 minutes.  Formation of these 
vesicular-like structures perhaps reflected trafficking from early endosomal to 
late endosomal-like compartments.  The early stages of the vesicular-like 
formation seemed to be more obvious for liD6A and liΔ6 compared to liWT 
and would be consistent with the quicker internalization rates seen for both 
liD6A and liΔ6.  The next major change was seen at 180 minutes where the 
dotty ‘sandy’ staining probably represented the continual movement of liWT 
and the mutants (D6A and liΔ6) through the various organelles and as well as 
some degradation taking place.  Surprisingly, prominent staining was still 





Table 3.1 Changing morphology of intracellular structures at various 
time-points 
 















3.6 The li and mutant constructs co-localize with EEA1 upon 
internalization. 
Since the IF data showed a difference in the internalization rates between liWT 
and the mutants D6A and liΔ6 and there were changes in the morphology of the 
intracellular structures at various stages after endocytosis, we wanted to 
compare the trafficking of wild type li and the mutants through early endosomal 
structures.  The intracellular fate of li and mutant constructs after endocytosis 
has been traced in previous published work (Pond et al, 1995; Kang et al., 1998) 
but those studies did not use any endosomal markers.  Therefore we wanted to 
investigate structures observed in the IF data above using early endosomal 
markers. 
As for the experiments above L2 cells were transfected with liWT and the 
mutant constructs all containing a C-terminus FLAG tag.  The cells were 
incubated on ice using the same antibody against the FLAG tag.  The cells were 
then fixed, permeabilized and stained for EEA1, which is known to be a marker 
for early endosomes.  
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As shown in figure 3.7A and 3.7B, at 5 minutes, punctuate structures that co-
localized with EEA1 began to appear for both the liΔ6 and the D6A mutant.  At 
this time point, no co-localization with EEA1 positive structures was evident 
for liWT.  At 10 minutes, the mutants were found in an increasing number of 
EEA1 positive vesicles and co-localization of liWT with EEA1 was also 
observed but to a lesser extent.  At this time point there were still significantly 
fewer EEA1 co-localized spots for the liWT compared to both the mutants (see 
figure 3.7B).  By 15 minutes, all of the three li constructs (liWT and the 
mutants) displayed a comparable number of co-localized EEA1 positive spots.  
At 20 minutes the number of co-localized spots started to decline for all three li 
constructs with the mutants showing a far steeper decline.  Interestingly, the 
number of co-localized spots for the liWT transfected cells was significantly 
greater at this time point compared to the cells transfected with either of the 
mutant constructs.  This is reflects a quicker trafficking of the mutants along the 
endocytic pathway.  By 30 minutes partially EEA1 co-localized structures 
became more prominent, indicating movement out of the EEA1 positive 
compartments.  By this time point, there was no longer any significant 
difference in the number of co-localized points between liWT and the mutants.  
 
3.7. li and mutants form large vesicular-like structures 
Since the wild type li and mutants were still found in some EEA1 positive 




As previous, L2 cells were transfected separately with li or one of the mutants 
and incubated with a monoclonal antibody to the FLAG tag.  The cells were 
then incubated at 370C without antibody for various time intervals. The cells 
were then fixed, permeabilized and stained for EEA1. 
As seen in figure 3.8, at 60 minutes there was very little co-localization with 
EEA1 evident for li or any of the mutant constructs.  Instead, there were many 
structures which showed partial co-localization, or that were adjacent to EEA1 
positive structures (thick white arrows).  Interestingly, there was the formation 
of larger vesicular-like structures (indicated by the yellow arrows).  These were 
more prominent from 90 minutes. 
The coinciding of the movement out of EEA1 structures by liWT and the 
mutants with the appearance of the first vesicular-like structures suggests that 



























Figure 3.6A Internalization in L2 cells at various time points. 
L2 cells were seperately transfected with c-Myc-li-FLAG construct (wild type li, liWT) 
and the mutant li construct c-Myc-liΔ6-FLAG (truncated li, liΔ6).  The cells were 
incubated on ice with mouse monoclonal antibody against the FLAG tag at the C-
terminus. Cells were then transferred at 370C and 5% CO2 and incubated for the 
indicated time intervals.  The cells were then fixed with methanol and probed with 
FITC-conjugated goat anti-mouse IgG.  White arrows indicate puncate structures. 
Yellow arrows indicate vesicular-like structures.  Images were taken using the BX60 at 
100X.  The figures are representative of three independent experiments.  








































































Figure 3.6B Internalization in L2 cells at various time points. 
L2 cells were seperately transfected with c-Myc-li-FLAG construct (wild type li, liWT) 
and a mutant li construct (liD6A).  The cells were incubated on ice with mouse 
monoclonal antibody against the FLAG tag at the C-terminus. Cells were then 
transferred at 370C and 5% CO2 and incubated for the indicated time intervals.  The 
cells were then fixed with methanol and probed with FITC-conjugated goat anti-mouse 
IgG.  White arrows indicate puncate structures.  Yellow arrows indicate vesicular-like 
structures.  Images were taken using the BX60 at 100X.  The figures are representative 















Figure 3.6C Number of punctate structures present over various time- points. 
The number of distinct punctate structures was counted for liWT and li∆6 over many 
cells for each of the time-points shown and the average calculated.  Error bars; 
Standard deviation.  Statistical significant differences to the liWT values is shown by 

















Figure 3.6 D Proportion of vesicular-like structures. 
For the time points shown, the number of vesicular-like structures was counted for a 
number of cells.  For each cell the number of vesicular-like structures was expressed as 
a percentage of the total number of structures. (The total number of structures 
comprised the number of distinct punctate structures together with the vesicular-like 
structures).  Vesicular-like structures are defined as those structures consisting of small 
distinct dots that assume a vesicular-like arrangement to give the appearance of a ‘tyre-
like’ structure.  The punctate structures are defined as the small distinct dots that under 
immunofluorescence do not give the appearance of ‘tyre-like’ structures.  The values 
are expressed as averages for each time-point.  Error bars; Standard deviation.  
Statistical significant differences to the liWT values is shown by the asterisk, *; p < 













Figure 3.6E Number of punctate structures present over various time- points. 
The number of distinct punctate structures was counted for liWT and liD6A over many 
cells for each of the time-points shown and the average calculated.  Error bars; 
Standard deviation.  Statistical significant differences to the liWT values is shown by 
the asterisk, *; p < 0.05.  For the 15 minute time-point, the value for the liWT is 


















Figure 3.6 F Proportion of vesicular-like structures. 
For the time points shown, the number of vesicular-like structures was counted for a 
number of cells.  For each cell the number of vesicular like structures was expressed as 
a percentage of the total number structures. (The total number of structures comprised 
the number of distinct punctate structures together with the vesicular-like structures).  
Vesicular-like structures are defined as those structures consisting of small distinct dots 
that assume a vesicular-like arrangement to give the appearance of a ‘tyre-like’ 
structure.  The punctate structures are defined as the small distinct dots that under 
immunofluorescence do not give the appearance of ‘tyre-like’ structures.  The values 
are expressed as averages for each time-point.  Error bars; Standard deviation.  
Statistical significant differences to the liWT values is shown by the asterisk, *; p < 

























Red staining: EEA1 





 Figure 3.7A Double-labelling in transfected L2 cells for li and EEA1. 
L2 cells were separately transfected with one of the plasmid constructs of li: the c-
Myc-li-FLAG construct (wild type li, liWT); the c-Myc-li D6A-FLAG (liD6A); or the 
deletion mutant li construct which lacks the first six N-terminal amino acids (liΔ6).  
The cells were incubated on ice with mouse monoclonal antibody against the FLAG 
tag at the C-terminus.  Cells were then transferred to 370C and 5% CO2 and incubated 
for the indicated time intervals followed by fixation with paraformaldehyde, and 
permeabilization with saponin.  Cells were then incubated with rabbit anti-EEA1 
antibody and probed with FITC-conjugated goat anti-mouse IgG to detect li (shown in 
green) and cy3 goat anti-rabbit IgG to detect EEA1 (shown in red).  White arrows 
indicate co-localization.  Image: Olympus confocal, magnification, 100X using a 2x 
zoom. Bar, 5µm.  The figures are representative of four independent experiments.  









Figure 3.7B Graphical presentation of the proportion of EEA1 spots. 
The number of EEA1 positive spots that co-localized with liWT or the mutants (shown 
by the yellow co-localized staining) were counted and expressed as a percentage of the 
total number of spots (yellow and green) for liWT and each of the mutants.  For the ‘0 
minute’ time-point, no co-localization was evident for liWT or either of the mutants. 
Error bars; Standard deviation.  Statistical significant differences to the liWT values is 
shown by the asterisk, *; p < 0.05.  For the 20 minute time-point, the value for the 
liWT is significantly greater than of either of the mutants.  
 
3.8 li and mutants do not co-localize with LAMP 1 
Since the larger vesicular-like structures were evident at a point corresponding 
to post EEA1 positive compartments, that is, when liWT and the mutants had 
already trafficked out of the EEA1 positive compartments, we were interested 




Transfected L2 cells with liWT or the mutants were incubated with antibody 
against the FLAG tag on ice and the cells were then placed in media to allow 
the antibody to endocytose.  The cells were then fixed, permeabilized and 
stained for LAMP1, which is a marker for late endosomes. 
Surprisingly, as seen in figure 3.9, neither li nor the mutants showed any co-
localization with the LAMP1 marker not even after 120 minutes.  Instead there 
were many punctuate structures that appeared to be clustered with LAMP1 and 
these were seen especially within the larger vesicular-like structures (shown by 
the thick white arrows).  This indicated that neither li nor the mutants had 
reached LAMP1 positive compartments even after 120 minutes.  
The results for this staining differed from that in part I where co-localization 
with LAMP1 compartments was evident.  However it must be emphasized that 
the staining in Part I is under steady state conditions after expression of the 
transfected pDMyc-li had taken place.  In this staining li is viewed in the 
context of the intracellular population of li molecules expressed at various 
stages and present at different locations inside the cell.  Hence some of the li 
molecules would be en route to the endocytic compartments via the plasma 
membranes while other li molecules would be trafficking directly from the ER.  
By contrast, in the chase experiments in part II, a particular population of li 
molecules was traced from the time the li molecules were internalized from the 


















Red staining: EEA1 




 Figure 3.8 Double-labelling of transfected L2 cells for li and EEA1 post-30 
minutes  
L2 cells were separately transfected with one of the plasmid constructs of li: liWT, 
liD6A or li6Δ.  The cells were incubated on ice with mouse monoclonal antibody 
against the FLAG tag as previously described then chased for the indicated times at 
370C and 5% CO2.  Cells were then fixed and incubated with rabbit anti-EEA1 antibody 
and probed with FITC-conjugated goat anti-mouse IgG to detect li (shown in green) 
and cy3 goat anti-rabbit IgG to detect EEA1 (shown in red).  Thin white arrows 
indicate co-localization; thick white arrows indicate partial co-localization; yellow 
arrows indicate vesicular-like structures.  Image: Olympus confocal; magnification, 
100X using a 2x zoom. Bar, 5µm.  The figures are representative of two independent 
experiments.  Representative cells are shown for each time point.  
 
3.9 Conclusion II 
In the course of internalization, the staining pattern for li and the mutants 
showed a series of changing morphologies regarding the intracellular structures.  
The changes in the intracellular structures observed for the IF data at around 20 
minutes coincided with a decline in EEA1 positive compartments as larger 
vesicular-like structures began to form.  This suggests movement from the early 
endosomal compartments to compartments further along the endocytic route. .  
Surprisingly, these were negative for LAMP 1 even 2 hours after internalization 

























Red staining: LAMP1 





 Figure 3.9   Double labelling of transfected L2 cells for li and LAMP1. 
L2 cells were separately transfected with either of liwt, liD6A or li6Δ.  The cells were  
incubated on ice with mouse monoclonal antibody against the FLAG tag as previously 
described then transferred for the indicated times at 370C and 5% CO2.  Cells were then 
fixed and incubated with rabbit anti-LAMP1 antibody and probed with FITC-
conjugated goat anti-mouse IgG to detect li (shown in green) and cy3 goat anti-rabbit 
IgG to detect detect LAMP1 (shown in red).  Thick white arrows indicate vesicular 
structures.  Image: Olympus confocal; magnification, 100X using a 2x zoom. Bar, 5µm.  





















4.1 Part 1 Effect of Nitric Oxide Synthase on the Trafficking of li 
Previous reports have shown that NOS2 in mouse DCs can interact with li at a 
region very near the DQRDLI motif, thus protecting li from proteolytic 
degradation by caspases (Huang et al., 2008).  This happened under stimulation 
by LPS.  Furthmore, NOS2 was found to co-localize with li at the ER-like 
region and at the endosomal-like regions which represent important 
intracellular regulation points for li.  In the ER, li is assembled together with 
MHC Class II molecules which facilitate its egress from the ER (Creswell, 
1994).  In the endosomal compartments, li undergoes degradation to a small 
molecule called CLIP which is then exchanged for the antigenic peptide 
(Byrant et al., 2002).  Hence we wanted to find out if interaction of NOS2 with 
li affects the intracellular trafficking of li in conditions of high NOS2 
expression.  
We looked at the distribution of li between the ER and the endosomal 
compartment.  This represents the trafficking of li from its assembly to its final 
destination.  We performed immunofluorescence (IF) in L2 cells under 
conditions of high NOS2 expression by co-transfecting these cells with li and 
NOS2 to see the intracellular location of li under these conditions.  We also 
looked at this distribution by subcellular fractionation and whether there was a 
change in distribution of li between the endosomal compartments and the ER-
enriched regions under conditions of high NOS expression.  Both the IF results 
and the subcellular fractionation of li showed a difference in the distribution of 
li between NOS transfected and control cells.   
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In the IF data, li was confined to the perinuclear region under conditions of 
NOS2 overexpression.  This corresponded to the co-localization of li with 
NOS2.  In the subcellular fractionation, in both the vector control and the 
NOS2-transfected cells li was distributed across the ER-enriched fractions as 
well as the LAMP1 enriched fractions.  However in the NOS2 transfected cells, 
a higher proportion of li was present in the ER-enriched fraction.  Hence, taking 
the IF data together with the subcellular fractionation outcome would indicate 
that NOS2 retains li in the ER-like region and that under conditions of high 
NOS2 expression this occurs through interaction of li with NOS2.  
In the human the p35 isoform of li contains an ER-retention factor (Schutze et 
al., 1994; Khalil et al., 2003; Khalil et al., 2003).  This is not present in the 
mouse (Creswell, 1994).  Hence, in mouse DCs NOS2 may act as an ER-
retention factor by binding to li.  High NOS2 expression was shown to occur in 
conditions where the DC is activated (Huang, et al., 2008).  Furthermore, there 
is a brief upregulation in the levels of li upon DC activation (Villandagos, et al., 
2005).  The ER retention mechanism would ensure proper assembly of li and 
MHC Class II molecules in the ER before egress.  It may also act to regulate the 
trafficking to the endocytic compartments.  In activated DCs, high levels of 
NOS2 inhibit caspase activity (Huang, et al., 2008).  Hence the ER retention 
may serve to co-ordinate the flow of li to ensure optimal antigen presentation 
efficiency.  
Interestingly, when we decided to investigate the binding of γ-adaptin to NOS2, 
we found that there was partial co-localization of γ-adaptin with li at the ER 
region.  There was partial co-localization with li, calrecticulin and γ-adaptin.  
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We suspect an involvement γ-adaptin in this region.  Even though γ-adaptin is 
known to function at the TGN (Robinson, 2004), there may still be an 
unidentified role for γ-adaptin in this region.  Since γ-adaptin appears to be 
involved in the trafficking of li, it may be possible that binding of NOS2 to li 
interferes with the binding of γ-adaptin because NOS2 binds very near the di-
leucine based motif.  
We showed that li does interact with γ-adaptin in the cell by a co-
immunoprecipitation assay.  This produced a faint but clear band that 
corresponded to p31.  This is significant because binding of γ-adaptin with li in 

















4.2 Part II Internalization of li from the Plasma Membrane 
The cytoplasmic tail of li has two di-leucine based sorting signals that direct its 
trafficking to the endosomal/lysosomal compartments, either directly from the 
TGN, or via the plasma membrane where li would then be internalized (Hansen, 
et al., 1996).  However li is expressed on the cell surface for only a very brief 
time having an estimated half life of less than 5 minutes (Roche et al., 1992). 
High turnover rate of li has been documented in cells expressing MHC Class II 
and in cells expressing li alone.  Biochemical studies using iodinated antibodies 
to the C-terminus of li showed that li is rapidly degraded after being 
internalized (Ong et al., 1999).  These findings support the IF observations by 
Roche and co-workers that outlined various stages of changing vesicular 
structures in a time course following internalization of li from the plasma 
membrane to steady state conditions, when li was degraded (Roche et al., 1992).   
Our results are in agreement with those of Roche in that that clear stages can be 
demarcated in the pattern of appearance of intracellular-like structures 
following internalization of li and the two mutant constructs (D6A and liΔ6) 
from the cell surface.  However in that study punctuate vesicles were evident 
even at 5 minutes pointing to a faster internalization rate and trafficking through 
the endocytic compartments.  The difference in internalization rate may be 
accounted for by the different cell lines used.  The invariant chain can have 
variable expression and different internalization rates amongst different cell 
lines (Henne et al., 1995). 
We first observed punctuate structures at 5 minutes, probably representing 
assembly of coated pits which began to change into structures with vesicular-
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like appearance at 15 minutes and 20 minutes.  This correlated with the 
confocal studies which showed increasing co-localization of li in EEA1 positive 
compartments from 10 minutes and peaking at the 15 minute time-point.  The 
vesicular-like structures seen in the IF most likely correspond to movement of 
the li chains through early endosomal compartments.  Interestingly, the 
formation of vesicular-like structures at 20 minutes coincided with a decrease in 
EEA1 co-localization.  Instead, li was seen in an increasing number of 
compartments that were adjacent to EEA1 positive compartments.  This may 
indicate that the small vesicles appearing in the IF pictures correspond to post 
early endosomal structures.   
It is noteworthy though that after 15 minutes Roche and co-workers reported 
that detection of the internalization antibody decreases and disappears by 180 
minutes (Roche et al., 1992).   
Our experiments show a marked difference with those results.  We were still 
able to observe intracellular staining for li and the mutants even at 180 minutes.  
This may indicate that the wild type li and the mutants (D6A and liΔ6) had not 
reached the degradative late endosomal compartments and may reflect a 
different pathway taken by liWT and the mutants (D6A and liΔ6) upon 
reaching the later stages of the endocytic route. 
Another explanation that may account from these differences is that Roche used 
an antibody that bound directly to the C-terminus of li.  This was the same in 
studies that utilized a radioactive antibody for determining the turnover rate of 
li (Ong et al., 1999).  It may be possible that deeper in the endocytic pathway, 
where it becomes increasingly more acidic (Landsverk et al., 2009), the 
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antibody may detach.  Hence, the degradation seen might actually in part have 
been the antibody that detached and became diffused and undetectable. 
However in our case we used an antibody against a flag tag which is likely to 
bind with a high affinity. 
Surprisingly however, even after 2 hours no co-localization was detected with 
the late endosomal marker LAMP1.  However li was found to be in clusters 
near the LAMP1 positive vesicles perhaps representing prelysosomal 
compartments.   
Perhaps one factor that may account for these differences is the c-Myc tag.  
However this is unlikely because it has not been shown to contain sorting 
signals and it has been used extensively as tags.  Hence it is believed that these 
changes observed are not an artefact. 
The changes in morphology reflect the trafficking of li through the endocytic 
pathway.  Studies by Kleijmeer and co-workers identified 6 distinct types of 
endocytic compartments in human B cells and five in mouse cells.  This was 
done by morphological examination of compartments in B lymphoblastoid cells 
after pulsing endocytic markers and then tracing the movement of these 
markers in the various compartments.  The invariant chain was found mainly in 
multivesicular compartments that were characterized as located downstream 
from the early endosomes (Kleijmeer et al., 1997).   
However different findings were obtained experiments by Romagnoli and co-
workers which showed the formation of large vesicular structures under 
conditions of high li expression which were described as being altered early 
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endosomes having properties particular to both early sorting endosomes and 
compartments deeper in the endocytic pathway but negative for LAMP1.  At 
low expression levels li was found in late/endosomal compartments.  
Furthermore, these large vesicular structures appeared to retain material 
destined for late endosomes, and this condition was dependent on the 
cytoplasmic tail of li (Romagnoli et al., 1993). 
Our results do not show in general the formation of very large vesicular 
structures, but interestingly, vesicular-like structures were prominent even at 60 
minutes after internalization.  It may indicate regulation of the trafficking of li 
to another sub-compartment within the multivesicular system or delayed 
transport to the late endosomal structures.  Or alternatively, they may also 
represent a sub-compartment within the pre-lysosomal compartments. 
Electron microscopy morphological studies will shed further light on the 
morphology of this structure.  Furthermore the trafficking route of internalized 
li could be traced with markers destined for different destinations.  Examples of 
such markers will include the transferrin receptor, which constitutively cycles 
between the early endosomes and the cell surface, and other markers destined 
for late endosomes such as the Mannose -6- phosphate receptor.  This will make 
clear at what point li deviates from the trafficking along the endocytic route.   
It is interesting that when seen at steady state, there is evidence of co-
localization with LAMP1.  This may indicate that there are two pools of 
trafficking conditions for li.  For li that travels by a direct route to the 
endosomal compartments (which would represent staining after expression of li 
at steady state) li does travel to the LAMP1 positive compartments.  But for li 
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that travels by the indirect route via the plasma membrane, a different 
compartment is the destination. 
Another interesting finding is that both of the mutants internalized faster than 
the wild type li and appeared to reach the EEA1 positive compartments before 
wild type li.  At the 30 minute time-point, the difference was less obvious 
between the li and the mutants.  These findings were different to previous 
published findings where an alanine substitution for Asp6 within the DXXXLI 
motif had no effect on the internalization rate of li (Pond et al., 1995; Motta et 
al., 1995).  Furthermore the truncated construct that we used lacked the acidic 
clusters N terminal to the Leu7-Ile8 pair.  Asp2 to alanine and Asp 3 to alanine 
mutations were shown to have markedly reduced the internalization rate of li 
despite the presence of the Leu7-Ile8 pair (Pond et al., 1995). 
It must be noted that those experiments were performed in the context of one 
active leucine-based pair, where the other pair was either rendered non 
functional by mutation or deleted (Pond et al., 1995).  
In our situation we have observed the internalization of li with mutants in the 
presence of both of the leucine-based pairs.  Interestingly, in this context a D6A 
mutation and deletion of the first six amino acids actually resulted in an 
increase in the internalization rate.  This may imply that the two motifs, 
although independent (Bremnes et al., 1994), can work together and that the 
acidic amino acid cluster in the di-leucine based distal motif may act as a 
negative regulator of the internalization and trafficking of li in the context of 
both active leucine-base pairs.  Interestingly the ML motif was found to 
internalize less efficiently than the LI based motif (Bremnes et al., 1994).  This 
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may happen through the binding of another protein to the motif in addition to 
the adaptor complexes, which may require both di-leucine based motifs to be 
present. 
Of course, IF results are qualitative and they need to be supported by 
biochemical studies.  We attempted to analyze the internalization rate by flow 
cytometry using an indirect assay.  Basically this involved binding of the FLAG 
antibody to transfected L2 cells on ice and then chasing for various time points 
(2 minutes, 5 minutes and 10 minutes) at 370C.  The cells would then be fixed 
and permeabilzed and labelled with the secondary antibody.  However the low 
intensity of the surface staining and high background readings yielded 
inconsistent results.  Even though we did find on more than one occasion that 
the mutants internalized faster than the wild-type, it was not always the case. 
Attempts to generate stably transfected L2 clones only gave cells expressing 
low levels of li and mutants that in the flow cytometry assay were no more 
effective than the transient transfected cells.  An improvement that could be 
introduced to the assay would be to use directly labelled antibody against flag. 
This will avoid the second step of adding the secondary antibody.  This method 
will also allow direct measurement of antibodies that had been internalized.   
In conclusion we have shown that mutations in the sorting motif of li in the 
presence of the two active di-leucine pairs can affect the regulation in the 
trafficking of li and that after internalization li may take a different route within 






NOS2 was found to have an effect in the intracellular distribution of li.  
Mutations in the DXXXLI motifs (a truncated contruct lacking the first N-
terminal amino acids and a D6A mutation) affect the internalization rate of li.  
Both li and the mutants trafficked through EEA1 positive compartments but did 
not reach LAMP1 compartments even after 120 minutes after internalization.  
The mutant constructs lacking either the first 6 amino acids in the distal di-
leucine based motif or with a mutation at Asp6 to alanine both internalized 
faster compared to the wild-type li.  This was different to previous published 
findings where a similar truncation with respect to the presence of only the 
distal LI pair (where the ML pair was mutated to alanine) did not internalize.  
We postulate that the presence of both motifs acts as a regulation to the 
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